<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>US Tele-Medicine Blog &#187; insurance</title>
	<atom:link href="http://www.epatienthealthcare.com/blog/tag/insurance/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.epatienthealthcare.com/blog</link>
	<description>A Global Leader in Telemedicine</description>
	<lastBuildDate>Fri, 10 Feb 2012 21:55:04 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>More States Limiting Medicaid Hospital Stays</title>
		<link>http://www.epatienthealthcare.com/blog/2011/10/24/more-states-limiting-medicaid-hospital-stays/</link>
		<comments>http://www.epatienthealthcare.com/blog/2011/10/24/more-states-limiting-medicaid-hospital-stays/#comments</comments>
		<pubDate>Mon, 24 Oct 2011 22:01:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Insurance Issues]]></category>
		<category><![CDATA[Tele-Medicine]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[hospital stays]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Jacques von Speyer]]></category>
		<category><![CDATA[limiting]]></category>
		<category><![CDATA[medicaid]]></category>
		<category><![CDATA[states]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=13004</guid>
		<description><![CDATA[Advocates for the needy and hospital executives say the moves will restrict access to care, force hospitals to absorb more costs and lead to higher charges for privately insured patients. States defend the actions as a way to balance budgets hammered by the economic downturn and the end of billions of dollars in federal stimulus [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a rel="attachment wp-att-13005" href="http://www.epatienthealthcare.com/blog/2011/10/24/more-states-limiting-medicaid-hospital-stays/medicaa/"><img class="alignleft size-full wp-image-13005" title="medicaa" src="http://www.epatienthealthcare.com/blog/wp-content/medicaa.jpg" alt="" width="186" height="139" /></a></strong></p>
<p>Advocates for the needy and hospital executives say the moves will restrict access to care, force hospitals to absorb more costs and lead to higher charges for privately insured patients.</p>
<p>States defend the actions as a way to balance budgets hammered by the economic downturn and the end of billions of dollars in federal stimulus funds this summer that had helped prop up Medicaid, financed jointly by states and the federal government.</p>
<p>Arizona, which last year stopped covering certain transplants for several months, plans to limit adult Medicaid recipients <div class="toggle">to 25 days of hospital coverage a year, starting as soon as the end of October.</p>
<p>Hawaii plans to cut Medicaid coverage to 10 days a year in April, the fewest of any state.</p>
<p>Both efforts require federal approval, which state officials consider likely because several other states already restrict hospital coverage.</p>
<p><img src="data:image/png;base64,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" alt="" /></p>
<p>Private health insurers generally don&#8217;t limit hospital coverage, according to <a title="More news, photos about America's Health Insurance Plans" rel="nofollow" href="http://content.usatoday.com/topics/topic/America%27s+Health+Insurance+Plans" target="_blank">America&#8217;s Health Insurance Plans</a>, a trade group.</p>
<p>Rosemary Blackmon, executive vice president of the Alabama Hospital Association, said &#8220;for the most part hospitals do what they can&#8221; to provide care to Medicaid patients despite the limits.</p>
<p>In Arizona, hospitals won&#8217;t discharge or refuse to admit patients who medically need to be there, said Peter Wertheim, spokesman for the Arizona Hospital and Healthcare Association. &#8220;Hospitals will get stuck with the bill,&#8221; he said.</p>
<p>Driven by higher enrollment and medical costs, Medicaid spending was projected to rise an average of 11.2% in fiscal 2011, which ended in June, from $427 billion in 2010, according to the <a title="More news, photos about National Association of State Budget Officers" rel="nofollow" href="http://content.usatoday.com/topics/topic/National+Association+of+State+Budget+Officers" target="_blank">National Association of State Budget Officers</a>.</p>
<p>For fiscal 2012, the association estimated state Medicaid spending will rise 19%, largely because of the end of the federal stimulus dollars.</p>
<p>The program served 69 million people last year.</p>
<p>Matt Salo, executive director of the National Association of Medicaid Directors, said the hospital coverage limits reflect how states are &#8220;desperately looking for any and all levers to reduce Medicaid costs&#8221; within the law.</p>
<p>The federal Centers for Medicare and Medicaid Services is working with states to &#8220;provide them with flexibility to run their Medicaid programs and reduce their costs,&#8221; Medicaid director Cindy Mann said in a statement. At the same time, &#8220;we must also ensure the Medicaid program continues to meet the health care needs of the children, people with disabilities and the elderly whom it serves.&#8221;</p>
<p><strong>Source for Story: </strong></p>
<p>Kaiser Health News</p>
<p> </p>
</div>]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2011/10/24/more-states-limiting-medicaid-hospital-stays/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Health Care Costs Set to Increase for University of Minnesota Employees</title>
		<link>http://www.epatienthealthcare.com/blog/2011/08/10/health-care-costs-set-to-increase-for-university-of-minnesota-employees/</link>
		<comments>http://www.epatienthealthcare.com/blog/2011/08/10/health-care-costs-set-to-increase-for-university-of-minnesota-employees/#comments</comments>
		<pubDate>Wed, 10 Aug 2011 22:10:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Insurance Issues]]></category>
		<category><![CDATA[employees]]></category>
		<category><![CDATA[health care costs]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[increase]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[insurance claims]]></category>
		<category><![CDATA[Jacques von Speyer]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[university of Minnesota]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=10879</guid>
		<description><![CDATA[The University will pass an estimated 5 percent of UPlan costs to employees. Spurred by an impending slash in state funding, the administration is looking to compensate by cutting $12.7 million from employee health care. The nearly 18,000 employees on the University’s plan could face hikes in premiums or co-pays. The University will pass about [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="attachment wp-att-10880" href="http://www.epatienthealthcare.com/blog/2011/08/10/health-care-costs-set-to-increase-for-university-of-minnesota-employees/hcc/"><img class="alignleft size-full wp-image-10880" title="hcc" src="http://www.epatienthealthcare.com/blog/wp-content/hcc.jpg" alt="" width="275" height="183" /></a>The University will pass an estimated 5 percent of UPlan costs to employees.</p>
<p>Spurred by an impending slash in state funding, the administration is looking to compensate by cutting $12.7 million from employee health care.</p>
<p>The nearly 18,000 employees on the University’s plan could face hikes in premiums or co-pays. The University will pass about 5 percent of UPlan costs for 2012 over to employees, said Dann Chapman, director of employee benefits.</p>
<p>It’s not attractive, but the alternative — reducing health benefits and coverage, <div class="toggle">which the University isn’t considering — is even uglier.</p>
<p>The UPlan does not include undergraduate or graduate student health plans or resident/fellow plans.</p>
<p>Only 500 to 600 of the 18,000 eligible employees opt out of the UPlan. With medical premium and co-pay increases imminent, that number may increase.</p>
<p>“There’s a very intentional cost shift happening between the university and its employees,” Chapman said.</p>
<p><strong>How to slice the pie</strong></p>
<p>Gavin Watt chairs the Benefits Advisory Committee, a group with representatives from all classes of benefits-eligible employees — employees whose primary function at the University is work, not school.</p>
<p>On April 21, the committee sent President Bob Bruininks a letter admonishing a permanent cut in employee benefits to address “a budget shortfall that may well be temporary.”</p>
<p>Watt phrased it another way during an interview with the Minnesota Daily.</p>
<p>“Why are you, the University, taking this out of employees’ hides?” he asked.</p>
<p>The letter goes on to propose that the decreases should be distributed evenly, so the burden does not fall disproportionately on sick people. It recommends raising premiums, which are the same for everyone, instead of raising co-pays, which are paid at individual doctor visits.</p>
<p>As of now, the University pays 90 percent of the employee-only premium. It pays 85 percent of the cost of family coverage for the basic medical plan, according to the Office of Human Resources.</p>
<p>One proposal would be to decrease the 90 percent to 86.5 percent, and the 85 percent for families to 80 percent. In this scenario, premiums would go up by about a third.</p>
<p>Another model would be to divide the UPlan budget shortfall by the number of employees and take the dollar amount out of everyone’s paycheck.</p>
<p>The fixed cost turns out to be about $26 a pay period or $670 a year for each employee, Watt said.</p>
<p>Currently, single employees in the UPlan pay $25.40 per pay period, so their cost would more than double. Employees with a spouse or partner and children would pay $135.30 a pay period, a 24-percent increase with the $26 addition.</p>
<p>No cost-shifting proposal has been finalized, Watt said. The proposals are based on current projections of state cuts to higher education, though.</p>
<p>Discussion continues, pending the state’s final budget decision and collective bargaining.</p>
<p>The out-of-pocket costs go up more with medical care inflation, which has increased by about 3 percent in the last 12 months, according to the Bureau of Labor Statistics.</p>
<p>Chapman, a key participant in the UPlan cost shift, said the persistent increases in health care costs and medical inflation is out of control.</p>
<p>“It’s eating us alive,” he said.</p>
<p><strong>Medica holds the aces</strong></p>
<p>Another change around the bend is the University’s decision to hire a single company, Medica, for the next six years to run the administrative side of its health benefits program.</p>
<p>Unlike some of the other Big Ten schools, the University of Minnesota is self-insured. It acts as its own insurance company, assuming the risk and designing its own benefits packages.</p>
<p>The University contracts an administrative company that processes insurance claims, handles billing and forms contracts with hospitals, clinics and doctors.</p>
<p>The University expects to save $14 million over the six-year contract.</p>
</div>]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2011/08/10/health-care-costs-set-to-increase-for-university-of-minnesota-employees/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Lap-Band Surgery for Weight Loss Safe?</title>
		<link>http://www.epatienthealthcare.com/blog/2011/03/07/is-lap-band-surgery-for-weight-loss-safe/</link>
		<comments>http://www.epatienthealthcare.com/blog/2011/03/07/is-lap-band-surgery-for-weight-loss-safe/#comments</comments>
		<pubDate>Mon, 07 Mar 2011 20:20:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Odd Medical Practices]]></category>
		<category><![CDATA[Weight Management]]></category>
		<category><![CDATA[cost]]></category>
		<category><![CDATA[COSTS]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[gastric bypass surgery]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[inflatable silicon ring]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[lap-band]]></category>
		<category><![CDATA[obese]]></category>
		<category><![CDATA[procedure]]></category>
		<category><![CDATA[risks]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=6175</guid>
		<description><![CDATA[People used to have to be very obese to qualify for LAP-BAND surgery, a weight loss operation in which an inflatable silicon ring is wrapped around the stomach to create a small pouch, drastically limiting food consumption.  Until recently, the procedure was only approved for those with a body mass index (BMI) of 40 or [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="attachment wp-att-6176" href="http://www.epatienthealthcare.com/blog/2011/03/07/is-lap-band-surgery-for-weight-loss-safe/lapband/"><img class="alignleft size-medium wp-image-6176" title="lapband" src="http://www.epatienthealthcare.com/blog/wp-content/lapband-300x157.jpg" alt="" width="300" height="157" /></a>People used to have to be very obese to qualify for LAP-BAND surgery, a weight loss operation in which an inflatable silicon ring is wrapped around the stomach to create a small pouch, drastically limiting food consumption.  Until recently, the procedure was only approved for those with a body mass index (BMI) of 40 or above, or patients with a BMI of 35 or above, plus a severe obesity-related illness, such as heart disease or diabetes. Now the FDA has expanded the criteria to include people who have a BMI of 30, along with an obesity-related disorder.</p>
<p>That means 37 million more Americans are <div class="toggle"> potential candidates for the surgery. Yet the FDA also reports that in a US study of people with BMIs of 30 to 40 who were treated with the LAP-BAND, more than 70 percent had one or more side effects. The most common were vomiting and trouble swallowing, both of which were usually temporary. Consumer Reports recently wrote about the apparently high rate of dissatisfaction with the procedure: In a study discussed on the manufacturer’s website, of 299 LAP-BAND patients followed for three years after the operation, 25 percent underwent a second surgery to remove the band. What’s more, up to 18 percent of patients needed a repeat procedure to repair problems with the band or its access port.</p>
<p>How much of a concern are these issues, and how does LAP-BAND surgery’s risks and benefits stack up to those of gastric bypass, the most commonly performed weight-loss operation?  “The LAP-BAND has a similar rate of complications as gastric bypass, but that’s not an entirely fair comparison, since gastric bypass is a much bigger surgery that permanently alters the anatomy of the stomach, so complications of gastric bypass tend to be more serious,” says Ted Khalili, MD, founder of the Khalili Center for Bariatric Care in Beverly Hills, California.</p>
<p>As with all operations, the experience of the surgeon is a key factor in the success of weight-loss surgery, adds Dr. Khalili. “There’s a learning curve, and during the first 50 cases, it’s not unusual for a bariatric surgeon to have a complication rate of 5 percent, while one who has done 1,000 operations may have a complication rate of less than 1 percent.” If you’re considering weight-loss surgery, get a referral from your primary care doctor or another physician you trust. Most US weight-loss surgeons are members of the American Society for Metabolic and Bariatric Surgery and are also board-certified in surgery.</p>
<p>During your initial consultation, discuss the surgeon’s track record with the procedure you’re considering as well as the potential risks and benefits. Also ask what sort of follow-up program the surgeon offers, advised Dr. Khalili. “You don’t want the doctor to leave you on your own without any support program to help make the procedure a success.” Here’s an overview of the pros and cons of the two operations.  (Another procedure, called sleeve gastrectomy, is seldom used and had inferior weight-loss results to gastric bypass in a recent clinical trial in China.)</p>
<p><strong>LAP-BAND surgery</strong></p>
<p>What is it? LAP-BAND is the brand name of a FDA-approved device used for an operation called gastric banding. The procedure is performed through small incisions in the abdomen. It involves placing an inflatable silicone ring around the upper portion of the stomach to create a small pouch. The band can be tightened by adding saline solution, like blowing up a donut-shaped balloon. It’s connected to an access port positioned underneath the skin of the abdomen, which is used to add or remove fluid to adjust the tightness.</p>
<p><strong>Who is an ideal candidate? </strong>To meet medical criteria for gastric banding, you must have a BMI of 40 (about 100 pounds overweight for an average man, or 80 pounds overweight for an average woman), or a BMI of 30 plus a serious obesity-related disorder, such as sleep apnea, heart disease, type 2 diabetes, high blood pressure, or hypercholesterolemia. To be an ideal candidate, you should also have tried dieting without success, says Dr. Khalili. “Your eating patterns are also important, since someone who grazes with frequent small meals or drinks a lot of sugary beverages may not have much weight loss with banding.”</p>
<p><strong>What to expect:</strong> Because the band prevents food from rapidly exiting the stomach, says Dr. Khalili, “you get a sensation of fullness after eating four to six ounces of food. Consuming more than that is likely to trigger vomiting.” Typically, patients he treats shed an average of 10 to 20 pounds within two months of the operation, and after that, two to five pounds a month. A recent study compared 100 morbidly obese patients (BMI above 40) who underwent LAP-BAND surgery with 100 similar patients treated with Roux-en-Y gastric bypass. After one year, the gastric bypass group had lost an average of 64 percent of their excess pounds, compared to a 36 reduction for the LAP-BAND group. However, LAP-BAND typically causes slower weight loss, which can continue for two years or longer, points out Dr. Khalili, so the study may not have lasted long enough to compare the full long-term weight loss of the two procedures.</p>
<p><strong>Potential risks:</strong> Serious side effects of LAP-BAND surgery are relatively rare. One of the most common problems, affecting 5 to 10 percent of patients, is slippage of the band, requiring a repeat procedure to reposition it. Another risk is that the band could break, also requiring repeat surgery. A less common problem is erosion of the band into the stomach, a serious side effect that requires hospitalization. All patients are likely to need periodic adjustments of the amount of fluid in the band, which can be done in a brief outpatient visit to the doctor. As with any operation, there is a potential risk of infections, anesthesia reactions, and excessive bleeding, though these seldom occur. The most common side effects after surgery are trouble swallowing and vomiting, both of which usually disappear over time. Should you decide that you’re not happy with gastric banding, the ring can be removed, thus reversing the procedure.</p>
<p><strong>What it costs: </strong>and is it covered by insurance: In the past, some plans that covered gastric bypass didn’t cover gastric banding, but now plans that pay for weight loss operations typically cover both procedures, says Dr. Khalili. The average cost in the US ranges from $15,000 to $20,000.</p>
<p><strong>Gastric bypass surgery</strong></p>
<p>This weight-loss operation changes your digestive tract to redirect food. There are variations of this operation, but the most common is the Roux-en-Y procedure. During this surgery, which is usually performed through small incisions, the surgeon staples your stomach, which is normally the size of a football, across the top to create a pouch the size of an egg. The pouch is then separated from the rest of the stomach and connected to small intestine, so food bypasses the rest of the stomach and first part of the small intestine (the duodenum). This procedure both restricts the amount of food you can eat and reduces absorption of calories, thus promoting weight loss in two ways.</p>
<p><strong>Who is an ideal candidate? </strong>To qualify, you must have a BMI of 40 or higher or a BMI of 35 or above plus a serious obesity-related disorder, such as diabetes, high blood pressure, heart disease, sleep apnea or hypercholesterolemia. You should also be unable to lose weight through dieting and exercise.  The procedure isn’t for everyone, emphasizes Dr. Khalili. “It’s an even more permanent commitment than marriage, because you can’t get a divorce from this surgery, so it’s crucial to be thoroughly evaluated to make sure you’re ready for this major procedure that will change your life forever.” This procedure has particular benefits if you have type 2 diabetes, since 76 percent of obese diabetics in a recent study had improvement or even reversal of their disease within one year after gastric bypass, compared with 50 percent of diabetic LAP-BAND patients.</p>
<p><strong>What to expect:</strong> Pounds melt off more quickly with gastric bypass than with the LAP-BAND operation, with patients losing 64 percent of their excess weight in one year, according to a recent study.  As with the LAP-BAND procedure, you will need to make dramatic changes in your eating habits since you will only be able to consume a few ounces of food at a time and must eat slowly, chewing thoroughly to avoid pain and vomiting.</p>
<p><strong>Potential risks:</strong> While gastric bypass has a similar rate of complications to LAP-BAND surgery, they tend to be more serious. One of the most worrisome is severe infection (peritonitis) due to leakage of intestinal contents into the abdomen if the surgery to join the intestines to the stomach pouch isn’t correctly performed. This is more likely to occur if the surgeon is inexperienced with the procedure, but is relatively uncommon. Because the surgery is more extensive than LAP-BAND, the risk of blood clots is somewhat higher, but still relatively rare. A long-term risk of gastric bypass is vitamin deficiency, since fewer nutrients in food are absorbed after the surgery, so patients will typically need supplements.</p>
<p><strong>What it costs</strong>:  It is covered by insurance: Most plans will cover the surgery for patients who meet the medical criteria. However, some plans don’t pay for weight-loss surgery at all. The procedure costs about $20,000 to $30,000.</p>
</div>]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2011/03/07/is-lap-band-surgery-for-weight-loss-safe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Telemedicine Acknowledged by Medicare</title>
		<link>http://www.epatienthealthcare.com/blog/2010/11/26/telemedicine-acknowledged-by-medicare/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/11/26/telemedicine-acknowledged-by-medicare/#comments</comments>
		<pubDate>Fri, 26 Nov 2010 20:13:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[Tele-Medicine]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[E-Patients]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[medicaid]]></category>
		<category><![CDATA[medicaid services]]></category>
		<category><![CDATA[medicare]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=3679</guid>
		<description><![CDATA[American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. &#8220;Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians. … The Centers for Medicare &#38; Medicaid [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="attachment wp-att-3680" href="http://www.epatienthealthcare.com/blog/2010/11/26/telemedicine-acknowledged-by-medicare/ustm-logo/"><img class="alignleft size-full wp-image-3680" title="ustm logo" src="http://www.epatienthealthcare.com/blog/wp-content/ustm-logo.jpg" alt="" width="209" height="64" /></a>American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. &#8220;Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians. … The Centers for Medicare &amp; Medicaid Services is making changes to promote telemedicine. In June, the agency proposed new policies that would make it easier for hospital officials to credential physicians who provide telemedicine services at their facilities. And in January 2011, CMS will expand Medicaid coverage for remote services, including disease management training for patients with diabetes or kidney disease&#8221; (Krupa, 11/22).</p>
<p>Austin American-Statesman: &#8220;Tech executives say Austin is positioned to be a player in health care technology, thanks to its deep pool of business software talent that is comfortable working in a startup environment and has expertise in creating products that save companies money. &#8230; So far, a handful of promising venture-backed players have emerged. … All in all, hundreds of computer hardware, software and services companies are competing for a piece of the market, which accelerated in 2009 with the passage of the federal economic stimulus bill, which set aside $19 billion in incentives for health care information technology. By one estimate, the government&#8217;s push to spur health care computer spending will help drive global health care IT spending to $106 billion by 2014, up from nearly $89 billion this year (Hawkins, 11/21).</p>
<p>The (Newark, N.J.) Star-Ledger: &#8220;Under federal health care reform, doctors must convert to an electronic system capable of chronicling each patient visit, tracking their care and sharing that information with hospitals and other doctors by 2015 — or the federal government will withhold some of the money it reimburses them for treating Medicare and Medicaid patients. … But so far, neither the promise of incentive nor threat of punishment is enticing a large number of New Jersey doctors to make the big switch. Only 20 percent of physicians in New Jersey have incorporated electronic medical records into their daily practice, compared to nearly 30 percent nationally, state Health and Senior Services Commissioner Poonam Alaigh said&#8221; (Livio, 11/21).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/11/26/telemedicine-acknowledged-by-medicare/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fears and Facts about Antidepressants</title>
		<link>http://www.epatienthealthcare.com/blog/2010/11/03/fears-and-facts-about-antidepressants/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/11/03/fears-and-facts-about-antidepressants/#comments</comments>
		<pubDate>Wed, 03 Nov 2010 21:09:38 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Tele-Medicine]]></category>
		<category><![CDATA[Weight Management]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[facts]]></category>
		<category><![CDATA[fears]]></category>
		<category><![CDATA[health. healthcare]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Internet]]></category>
		<category><![CDATA[medical conditions]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[medication]]></category>
		<category><![CDATA[personality change]]></category>
		<category><![CDATA[studies]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>
		<category><![CDATA[weight gain]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=2484</guid>
		<description><![CDATA[Along with counseling, antidepressants are a common part of treatment for depression. And they are usually effective. Six out of 10 people treated with antidepressants feel better with the first one they try. If the first antidepressant medication doesn&#8217;t help, the second or third often will. Most people eventually find one that works for them. [...]]]></description>
			<content:encoded><![CDATA[<p><a rel="attachment wp-att-2950" href="http://www.epatienthealthcare.com/blog/2010/11/03/fears-and-facts-about-antidepressants/antid/"><img class="alignleft size-full wp-image-2950" title="antid" src="http://www.epatienthealthcare.com/blog/wp-content/antid.jpg" alt="" width="225" height="225" /></a>Along with counseling, antidepressants are a common part of treatment for depression. And they are usually effective. Six out of 10 people treated with antidepressants feel better with the first one they try. If the first antidepressant medication doesn&#8217;t help, the second or third often will. Most people eventually find one that works for them. Yet many people who could benefit from an antidepressant never try one, often because of fears and misconceptions about them, experts say.</p>
<p>Here are eight common fears about antidepressants, as well as facts that can help you decide if an antidepressant might be right for you.</p>
<p><strong>Fear:</strong> <strong>Antidepressants make you forget your problems rather than deal with them.</strong></p>
<p><strong>Fact:</strong> Antidepressants can&#8217;t make you forget your problems, but they may make it easier for you to deal with them. Being depressed can distort your perception of your problems and sap you of the energy to address difficult issues. Many therapists report that when their patients take antidepressants, it helps them make more progress in counseling.</p>
<p><strong>Fear: Antidepressants change your personality or turn you into a zombie.</strong></p>
<p><strong>Fact:</strong> When administered correctly, antidepressants will not change your personality. They will help you feel like yourself again and return to your previous level of functioning. (If a person who isn&#8217;t depressed takes antidepressants, they do not improve that person&#8217;s mood or functioning.) Rarely, people experience apathy or loss of emotions while on certain antidepressants. When this happens, switching to a different antidepressant may help.</p>
<p><strong>Fear: Taking an antidepressant will make me gain weight.</strong></p>
<p><strong>Fact:</strong> Like all drugs, antidepressants have side effects, and weight gain can be a common one of many of them. Some antidepressants <strong>may be more likely than others to cause weight gain; others</strong> may actually cause you to lose some weight. If this is a concern, talk with your doctor.</p>
<p><strong>Fear: If I start taking antidepressants, I&#8217;ll have to take them for the rest of my life.</strong></p>
<p><strong>Fact:</strong> Most people who take antidepressants need to take them continuously for six to nine months  not necessarily a lifetime. Once an antidepressant gets depression under control, you should work with your doctor to decide when to stop your medication and then decrease your dose gradually. Discontinuing them suddenly may cause problems such as headaches, dizziness, and nausea.</p>
<p><strong>Fear: Antidepressants will destroy my sex life.</strong></p>
<p><strong>Fact:</strong> Antidepressants can have an effect on sexual functioning. The problem is usually an inability to achieve orgasm rather than a lack of desire. But because depression itself decreases libido, a medication that eases depression may improve your sex life. As with other side effects, certain antidepressants may be more likely than others to cause sexual problems.</p>
<p><strong>Fear: Antidepressants are expensive and aren&#8217;t covered by insurance.</strong></p>
<p><strong>Fact:</strong> Antidepressants are usually covered by insurance plans with prescription drug coverage. The cost of antidepressant therapy varies widely, depending on the dosage, the drug you are taking, and whether it is available as a generic. Even without insurance coverage, it is possible to purchase a generic antidepressant for as little as $15 per month.</p>
<p><strong>Fear: Taking an antidepressant is a sign of weakness.</strong></p>
<p><strong>Fact:</strong> Like medical conditions such as diabetes or high cholesterol, major depression is a condition that often responds to medication. When depression interferes with your ability to function normally, seeking treatment is not a sign of weakness. It&#8217;s a sign of good self-care.</p>
<p><strong>Fear: Antidepressants increase the risk of suicide.</strong></p>
<p><strong>Fact:</strong> Studies in recent years have raised concerns that antidepressants may raise the risk of suicide among children, adolescents, and young adults. For example, a 2009 review in the <em>British Medical Journal (BMJ)</em> analyzed 372 studies involving nearly 100,000 people who were taking antidepressants. It found that compared to placebo, use of antidepressant drugs was associated with a small increased risk for suicidal thoughts in some children and young adults, have no effect on suicide risk among those 25 to 64, and reduce risk in those 65 and older.</p>
<p>In 2004, the FDA required manufacturers of antidepressants to revise their labels to include a black box warning statement about these risks.</p>
<p>Other studies paint a different picture. A 2006 study published in <em>PLoS Medicine</em> suggests that the use of antidepressants has saved thousands of lives. Data show that the U.S. suicide rate held fairly steady for 15 years prior to the introduction of the widely used antidepressant fluoxetine (Prozac) and then dropped steadily over 14 years while sales of Prozac rose. The research team found the strongest effect among women.</p>
<p>The bottom line: Regardless of your age or sex, it&#8217;s important to see a doctor immediately if you have suicidal tendencies or witness them in others.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/11/03/fears-and-facts-about-antidepressants/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>Medical Programs Missing Millions of Kids</title>
		<link>http://www.epatienthealthcare.com/blog/2010/09/09/medical-programs-missing-millions-of-kids/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/09/09/medical-programs-missing-millions-of-kids/#comments</comments>
		<pubDate>Thu, 09 Sep 2010 19:47:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Insurance Issues]]></category>
		<category><![CDATA[CHIP]]></category>
		<category><![CDATA[E-Patients]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[medicaid]]></category>
		<category><![CDATA[medical programs]]></category>
		<category><![CDATA[uninsured]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=1379</guid>
		<description><![CDATA[An estimated five million uninsured children in the United States were eligible for Medicaid or the Children&#8217;s Health Insurance Program (CHIP) but were not enrolled in either plan, according to a new report. The study published on Friday in the journal &#8220;Health Affairs&#8221; recommended policy reforms and broader efforts to get uninsured children into government [...]]]></description>
			<content:encoded><![CDATA[<p>An estimated five million uninsured children in the United States were eligible for Medicaid or the Children&#8217;s Health Insurance Program (CHIP) but were not enrolled in either plan, according to a new report.</p>
<p>The study published on Friday in the journal &#8220;Health Affairs&#8221; recommended policy reforms and broader efforts to get uninsured children into government medical programs, including the use of income tax data for automatic enrollment.</p>
<p>An estimated 7.3 million children were uninsured on an average day in 2008 and 65 percent of them were eligible for Medicaid of CHIP coverage, the report said.</p>
<p>President Barack Obama, who signed landmark healthcare reforms into law in March, has made providing health care to all Americans a top priority of his administration.</p>
<p>Thirty-nine percent (1.8) million of eligible uninsured children live in just three states &#8212; California, Texas and Florida, the report by the Washington-based Urban Institute Health Policy Center said. Sixty-one percent (2.9 million) of uninsured children live in 10 states, the report said.</p>
<p>&#8220;This new data will help us to focus our efforts and our grant funding where they are most needed,&#8221; U.S. Secretary of Health and Human Services Kathleen Sebelius said in a statement. &#8220;We now have a much better sense of where most uninsured children live, and which communities may need more help.&#8221;</p>
<p>Medicaid is the joint state-federal health plan for the poor, disabled and elderly. CHIP provides low-cost coverage for children in families who earn too much to qualify for Medicaid but cannot afford private health insurance coverage.</p>
<p>&#8220;No child should have to skip a doctor&#8217;s appointment or go without the medicine they need because their family can&#8217;t pay,&#8221; Sebelius said, challenging state and local officials to &#8220;find and enroll those five million kids.&#8221;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/09/09/medical-programs-missing-millions-of-kids/feed/</wfw:commentRss>
		<slash:comments>40</slash:comments>
		</item>
		<item>
		<title>Hospital ‘Center of Excellence Program’ launched by US Tele-Medicine</title>
		<link>http://www.epatienthealthcare.com/blog/2010/09/06/hospital-%e2%80%98center-of-excellence-program%e2%80%99-launched-by-us-tele-medicine/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/09/06/hospital-%e2%80%98center-of-excellence-program%e2%80%99-launched-by-us-tele-medicine/#comments</comments>
		<pubDate>Mon, 06 Sep 2010 22:49:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Press Release]]></category>
		<category><![CDATA[clinics]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[hospitals]]></category>
		<category><![CDATA[income]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[patient refferals]]></category>
		<category><![CDATA[revenue]]></category>
		<category><![CDATA[Tele-Medicine Care]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=1339</guid>
		<description><![CDATA[For Immediate Release: Hospital ‘Center of Excellence Program’ launched by US Tele-Medicine Qualifying hospitals and clinics can now earn revenues derived from Telemedicine referrals.  In addition, these hospitals and clinics will access a national Telemedicine provider as a solution to overflow issues and to support expansion. “The global world of Telemedicine opens to these facilities [...]]]></description>
			<content:encoded><![CDATA[<p>For Immediate Release:</p>
<p><span style="text-decoration: underline;">Hospital ‘Center of Excellence Program’ launched by US Tele-Medicine</span></p>
<p>Qualifying hospitals and clinics can now earn revenues derived from Telemedicine referrals.  In addition, these hospitals and clinics will access a national Telemedicine provider as a solution to overflow issues and to support expansion.</p>
<p>“The global world of Telemedicine opens to these facilities without the major up-front costs and effort normally associated with developing an in-house Telemedicine department,” said Gideon Ilumin, Director of Business Affairs for US Tele-Medicine.</p>
<p>US Tele-Medicine, a national health care provider based in Beverly Hills, CA and licensed in twelve states, providing General Practice and Family Practice services, is forming joint ventures with hospitals and clinics in its territories. The program is called “Center of Excellence” and identifies these facilities as telemedicine approved.   In the agreements, US Tele-Medicine refers its telehealth patients to the joint venture partners for consultation, imaging, surgical procedures, and specialty care.</p>
<p>“We present a number of solutions. First we increase hospital/clinic revenues, as the nature of telemedicine referrals generally involve more expensive specialty procedures that a telemedicine doctor cannot accomplish on the phone or internet,” said Ilumin.  “Secondly our infrastructure brings a solution to clinics and hospitals wishing to expand their patient base, yet finding they are restrained by finances, personnel or structural limitations,” said Ilumin.</p>
<p>US Tele-Medicine supplies remote and wireless monitoring devices to patients that measure a number of vital signs and transmit that information to the US Tele-Medicine EMR (EHR) platform, for medical oversight.  The strength of US Tele-Medicine is providing management for many chronic conditions in a less expensive environment such as the home or office.</p>
<p>Randy Ryder, US Tele-Medicine’s Director of Patient Services says, “Most clinics and hospitals need to expand to stay afloat.  I understand that, but I also know that many people come to these facilities and wait, sometimes for hours, to see a physician, when all they are seeking is basic primary care or some support for a chronic condition. US Tele-Medicine is especially effective at treating this type of patient.”</p>
<p>“Imagine the improvement in ease of operation for a hospital or a clinic when you remove that patient load from over-utilizing facilities,” said Ryder.  “Hospitals can then concentrate on being hospitals, rather than Doctor’s offices, and expand their specialties or surgical centers, where their economic strengths come from.”</p>
<p>So what happens to these patients?  “They receive their care at home, in their offices or on the go,” answered Ryder. “Telemedicine is a modality proven to promote greater wellness, provide accessible medical care at reduced costs and do it immediately.”</p>
<p>Ilumin said “We are the most advanced telemedicine operation in the USA today, far ahead of others in the use of technology.  By referring their patients to US Tele-Medicine, hospitals and clinics enter the world of telemedicine without the substantial up-front investment.  Strategically this is very smart both financially and for reputations’ sake (marketing effectiveness) of that facility.  Adopting the “Center of Excellence” program increases revenues and demonstrates to the world the inclusivity and understanding of state-of-the art medicine as well as adding tremendous public prestige.”</p>
<p>For more information, go to www.ustelemedicine.com,</p>
<p>email: media@ustelemediicne.com, or call 800-498-1081</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/09/06/hospital-%e2%80%98center-of-excellence-program%e2%80%99-launched-by-us-tele-medicine/feed/</wfw:commentRss>
		<slash:comments>37</slash:comments>
		</item>
		<item>
		<title>Five Million California Adults Say They Are Mentally Stressed</title>
		<link>http://www.epatienthealthcare.com/blog/2010/08/07/five-million-california-adults-say-they-are-mentally-stressed/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/08/07/five-million-california-adults-say-they-are-mentally-stressed/#comments</comments>
		<pubDate>Sun, 08 Aug 2010 01:59:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Herbs]]></category>
		<category><![CDATA[Insurance Issues]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[health insurance]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[mental health]]></category>
		<category><![CDATA[mental health conditions]]></category>
		<category><![CDATA[mental health treatment]]></category>
		<category><![CDATA[psychological distress]]></category>
		<category><![CDATA[stress]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=1125</guid>
		<description><![CDATA[Almost 5 million California adults say they could use help with a mental or emotional problem, according to a survey released Wednesday by researchers at UCLA. About 1 million of them meet the criteria for &#8220;serious psychological distress.&#8221; However, only one in three people who perceive a need for mental health services or are in [...]]]></description>
			<content:encoded><![CDATA[<p>Almost 5 million California adults say they could use help with a mental or emotional problem, according to a survey released Wednesday by researchers at UCLA. About 1 million of them meet the criteria for &#8220;serious psychological distress.&#8221;</p>
<p>However, only one in three people who perceive a need for mental health services or are in serious distress have seen a professional for treatment, the survey found.</p>
<p>The survey was conducted among more than 44,000 adults as part of the 2005 California Health Interview Survey, administered through the UCLA Center for Health Policy Research. Since the survey was conducted, the recession probably has contributed to worsening mental health for even more people, said the lead author of the study, David  Grant.</p>
<p>The survey showed that lack of health insurance coverage was a major reason why people didn&#8217;t seek help &#8212; a situation that may be rectified somewhat by state and national mental health parity laws now in effect that require insurers to cover mental health conditions similarly to they way they cover physical conditions. (The final phase of the federal law went into effect on July 1.) However, stigma continues to be a barrier to mental health services. The survey found that men, people 65 and older, Latinos and Asians were less likely to seek help because of the stigma associated with mental or emotional problems. But being poor is the biggest barrier to care.</p>
<p>According to the survey:</p>
<ul>
<li>Women      were nearly twice as likely as men to say they needed help because they      felt sad, anxious or nervous (22.7% compared to 14.3%).</li>
<li>Adults      under age 65 were twice as likely to perceive the need for help (20.2%      compared to 9.2%).</li>
<li>The      poorest adults were more than five times as likely to report symptoms of      serious psychological distress compared to those living well above the      federal poverty level.</li>
</ul>
<p>&#8220;The findings also demonstrate a crucial need for continued efforts to expand mental-health services and to meet threats to such services caused by the ongoing state budget crisis in Sacramento; reduced state funding for local mental health programs and public insurance programs could be devastating to hundreds of thousands of Californians with mental health needs,&#8221; the authors wrote.</p>
<p>Mental health services always seems to be a big target when it comes to trimming state and local budgets. Lawmakers can get away with it, of course, because the stigma surrounding mental illness prevents people from protesting such cuts. Given the number of people in pain, according to this survey, it may be time for Californians to overcome the perceived stigma and demand expanded public funding and insurance coverage of mental health care.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/08/07/five-million-california-adults-say-they-are-mentally-stressed/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Coffee Extract Prevents Bad Breath</title>
		<link>http://www.epatienthealthcare.com/blog/2010/08/07/coffee-extract-prevents-bad-breath/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/08/07/coffee-extract-prevents-bad-breath/#comments</comments>
		<pubDate>Sun, 08 Aug 2010 01:43:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[bacterial]]></category>
		<category><![CDATA[bad breath]]></category>
		<category><![CDATA[breath]]></category>
		<category><![CDATA[breath mints]]></category>
		<category><![CDATA[cholesterol]]></category>
		<category><![CDATA[coffee]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[healthy food]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[mouthwash]]></category>
		<category><![CDATA[Tele-Medicine Care]]></category>
		<category><![CDATA[USTM Patients]]></category>
		<category><![CDATA[Weight Management]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=1115</guid>
		<description><![CDATA[We all know why Starbucks puts boxes of breath mints close to the cash register. Your morning latte can create a startling aroma in your mouth, strong enough to startle your co-workers too. But intriguing new research from Tel Aviv University by breath specialist Prof. Mel Rosenberg finds that a coffee extract can inhibit the [...]]]></description>
			<content:encoded><![CDATA[<p><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF /> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> <w:SplitPgBreakAndParaMark /> <w:DontVertAlignCellWithSp /> <w:DontBreakConstrainedForcedTables /> <w:DontVertAlignInTxbx /> <w:Word11KerningPairs /> <w:CachedColBalance /> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math" /> <m:brkBin m:val="before" /> <m:brkBinSub m:val="&#45;-" /> <m:smallFrac m:val="off" /> <m:dispDef /> <m:lMargin m:val="0" /> <m:rMargin m:val="0" /> <m:defJc m:val="centerGroup" /> <m:wrapIndent m:val="1440" /> <m:intLim m:val="subSup" /> <m:naryLim m:val="undOvr" /> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal" /> <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" /> <w:LsdException Locked="false" Priority="39" Name="toc 1" /> <w:LsdException Locked="false" Priority="39" Name="toc 2" /> <w:LsdException Locked="false" Priority="39" Name="toc 3" /> <w:LsdException Locked="false" Priority="39" Name="toc 4" /> <w:LsdException Locked="false" Priority="39" Name="toc 5" /> <w:LsdException Locked="false" Priority="39" Name="toc 6" /> <w:LsdException Locked="false" Priority="39" Name="toc 7" /> <w:LsdException Locked="false" Priority="39" Name="toc 8" /> <w:LsdException Locked="false" Priority="39" Name="toc 9" /> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" /> <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title" /> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" /> <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle" /> <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong" /> <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis" /> <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" /> <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" /> <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" /> <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote" /> <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6" /> <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" /> <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" /> <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" /> <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" /> <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title" /> <w:LsdException Locked="false" Priority="37" Name="Bibliography" /> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading" /> </w:LatentStyles> </xml><![endif]--><!--[if !mso]><span class="mceItemObject"   classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></span><br />
<mce:style><!  st1\:*{behavior:url(#ieooui) }st2\:*{behavior:url(#ieooui) } --></p>
<p><!--[endif]--> <!--[if gte mso 10]><br />
<mce:style><!   /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} --></p>
<p><!--[endif]--></p>
<p class="MsoNormal" style="line-height: normal;"><span>We all know why Starbucks puts boxes of breath mints close to the cash register. Your morning latte can create a startling aroma in your mouth, strong enough to startle your co-workers too. </span></p>
<p class="MsoNormal" style="line-height: normal;"><span>But intriguing new research from <span style="color: black;">Tel Aviv University by</span> breath specialist Prof. Mel Rosenberg finds that a coffee extract can inhibit the bacteria that lead to bad breath. New laboratory tests have shown that the extract prevents malodorous bacteria from making their presence felt ― or smelt. </span></p>
<p class="MsoNormal" style="line-height: normal;"><span>“Everybody thinks that coffee causes bad breath,” says Prof.  Rosenberg, “and it’s often true, because coffee, which has a dehydrating effect in the mouth, becomes potent when mixed with milk, and can ferment into smelly substances.” </span></p>
<p class="MsoNormal" style="line-height: normal;"><span>But not always: “Contrary to our expectations, we found some components in coffee that actually inhibit bad breath,” explains Prof.  Rosenberg. The findings were presented last month to members of the International Society for Breath Odor Research in Germany by Yael Gov, a researcher in Prof. Rosenberg&#8217;s laboratory</span></p>
<p class="MsoNormal" style="line-height: normal;"><strong><span>A “taster’s choice” for stopping bad bacteria</span></strong><span><br />
In the laboratory, the team monitored the bacterial odor production of coffee in saliva. In the study, three different brands of coffee were tested: the Israeli brand Elite coffee, Landwer Turkish coffee, and Taster’s Choice. Prof. Rosenberg expected to demonstrate the malodor-causing effect of coffee in an in vitro saliva evaluation developed by Dr.  Sarit Levitan in his laboratory. To his surprise, the extracts had the opposite effect.</span></p>
<p class="MsoNormal" style="line-height: normal;"><span>“The lesson we learned here is one of humility,” says Prof.  Rosenberg. “We expected coffee would cause bad breath, but there is something inside this magic brew that has the opposite effect.” </span></p>
<p class="MsoNormal" style="line-height: normal;"><span>Prof.</span><span> Rosenberg</span><span> would love to isolate the bacterial-inhibiting molecule in order to reap the biggest anti-bacterial benefits from coffee. “It’s not the raw extract we will use,” he says, “but an active material within it.” His latest discovery could be the foundation for an entirely new class of mouthwash, breath mints and gum. Purified coffee extract can be added to a breath mint to stop bacteria from forming, stopping bad breath at its source, instead of masking the smell with a mint flavor. </span></p>
<p class="MsoNormal" style="line-height: normal;"><span>Prof.</span><span> Rosenberg</span><span> previously developed a popular mouthwash sold widely in Europe, a pocket-based breath test, and an anti-odor chewing gum.</span></p>
<p><img src="file:///C:/Users/JvS/AppData/Local/Temp/moz-screenshot-2.png" alt="" /><img src="file:///C:/Users/JvS/AppData/Local/Temp/moz-screenshot-1.png" alt="" /></p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/08/07/coffee-extract-prevents-bad-breath/feed/</wfw:commentRss>
		<slash:comments>24</slash:comments>
		</item>
		<item>
		<title>Telemedicine Brings Immediate Relief</title>
		<link>http://www.epatienthealthcare.com/blog/2010/08/02/telemedicine-brings-immediate-relief/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/08/02/telemedicine-brings-immediate-relief/#comments</comments>
		<pubDate>Mon, 02 Aug 2010 21:18:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Tele-Medicine]]></category>
		<category><![CDATA[decrease medical costs]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[E-Patients]]></category>
		<category><![CDATA[health care]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[healthcare costs]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[insurance companies]]></category>
		<category><![CDATA[insuranmce payors]]></category>
		<category><![CDATA[Tele-Medicine Care]]></category>
		<category><![CDATA[telehealth]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=1100</guid>
		<description><![CDATA[August 2, 2010 United States of America 0 Telemedicine reduces the expense, eliminates the bother and time needed for people to receive the primary medical care they require. In rural America the Telemedicine effect is dramatic.   // // // // FOR IMMEDIATE RELEASE August 2, 2010 &#8212; For Immediate Release Telemedicine Brings Immediate Relief [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.free-press-release.com/news/20100802/">August  2, 2010</a> <a href="http://www.free-press-release.com/news-by-country/1-1.html">United  States of America</a></p>
<div>
<div>0</div>
<div>
<div><a title="Tweet ThisTwitter" href="http://www.addthis.com/bookmark.php?v=250&amp;winname=addthis&amp;pub=fpr&amp;source=tbx-250&amp;lng=en-US&amp;s=twitter&amp;url=http%3A%2F%2Fwww.free-press-release.com%2Fnews-telemedicine-brings-immediate-relief-1280780009.html&amp;title=Telemedicine%20Brings%20Immediate%20Relief%20-%20telemedicine%2C%20medical%20care%20system%2C%20chronic%20pain%20management&amp;ate=AT-fpr/-/-/4c5735786880e450/1&amp;CXNID=2000001.5215456080540439074NXC&amp;tt=0" target="_blank"><img alt="" /></a> <a title="Send to Facebook" href="http://www.addthis.com/bookmark.php?v=250&amp;winname=addthis&amp;pub=fpr&amp;source=tbx-250&amp;lng=en-US&amp;s=facebook&amp;url=http%3A%2F%2Fwww.free-press-release.com%2Fnews-telemedicine-brings-immediate-relief-1280780009.html&amp;title=Telemedicine%20Brings%20Immediate%20Relief%20-%20telemedicine%2C%20medical%20care%20system%2C%20chronic%20pain%20management&amp;ate=AT-fpr/-/-/4c5735786880e450/2&amp;CXNID=2000001.5215456080540439074NXC&amp;tt=0" target="_blank"><img alt="" /></a></div>
</div>
<p><script src="http://s7.addthis.com/js/250/addthis_widget.js#username=fpr" type="text/javascript"></script></div>
<h2>Telemedicine reduces the expense, eliminates  the bother and time needed for people to receive the primary medical  care they require.  In rural America the Telemedicine effect is  dramatic.</h2>
<p> <br />
 <script type="text/javascript">// <![CDATA[// <![CDATA[
google_ad_client = "pub-4140692434942764";
/* fpr3-1pr-top-468, created 4/12/10 */
google_ad_slot = "3401621084";
google_ad_width = 468;
google_ad_height = 15;
// ]]&gt;</script> <script src="http://pagead2.googlesyndication.com/pagead/show_ads.js" type="text/javascript">
</script><script src="http://pagead2.googlesyndication.com/pagead/expansion_embed.js"></script><script src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></script><script type="text/javascript">// <![CDATA[// <![CDATA[
google_protectAndRun("ads_core.google_render_ad", google_handleError, google_render_ad);
// ]]&gt;</script><ins><ins></ins></ins></p>
<div><script type="text/javascript">// <![CDATA[// <![CDATA[
google_ad_client = "pub-4140692434942764";
google_alternate_ad_url = "http://www.free-press-release.com/ads/pubarticles.html";
google_ad_width = 336;
google_ad_height = 280;
google_ad_format = "336x280_as";
google_ad_type = "text_image";
google_ad_channel = "8590001888+9259560495+1481821594";
google_color_border = "FFFFFF";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "666666";
google_color_url = "666666";
// ]]&gt;</script> <script src="http://pagead2.googlesyndication.com/pagead/show_ads.js" type="text/javascript"></script><script type="text/javascript">// <![CDATA[// <![CDATA[
google_protectAndRun("ads_core.google_render_ad", google_handleError, google_render_ad);
// ]]&gt;</script><ins><ins></ins></ins></div>
<p>FOR IMMEDIATE RELEASE<br />
August  2, 2010 &#8212;   	  For Immediate Release</p>
<p>Telemedicine Brings Immediate Relief</p>
<p>Dora Johnson calls upon her neighbor or  daughter whenever she needs to visit a Doctor.  She suffers from <a id="KonaLink0" href="http://www.free-press-release.com/news-telemedicine-brings-immediate-relief-1280780009.html#" target="undefined"><span style="color: #000000;">high  blood pressure</span></a> and arthritis  has wracked her legs into two misshapen appendages, which can no longer  support her weight without experiencing excruciating pain.  “It’s not  so much the pain anymore,” explains Dora, “that is a constant.  It is  the embarrassment I feel when bothering other people just to get me to  the doctor.  After a while you just forgo the frequent doctor visits and  do the best you can.”</p>
<p>When Dora does get her ride, she travels for thirty-five minutes to the  county general hospital where she waits for two-three hours to see a  physician.  “All they ever do is take my blood pressure and send me  home,” said Dora.  It seems that “they” also check her <a id="KonaLink1" href="http://www.free-press-release.com/news-telemedicine-brings-immediate-relief-1280780009.html#" target="undefined"><span style="color: #000000;">prescriptions</span></a>.</p>
<p>Dora and her friendly neighbor drove 50 miles and spent over four hours  just to have her blood pressure checked.  In addition to their expenses,  the hospital billed some payor $450 &#8211; $600, inclusive of the hospital  facility charges, for Dora’s visit.</p>
<p>This failing model of providing care is the  standard in the USA today.</p>
<p>Dora is a now a patient of US Tele-Medicine.  The Beverly Hills based <a id="KonaLink2" href="http://www.free-press-release.com/news-telemedicine-brings-immediate-relief-1280780009.html#" target="undefined"><span style="color: #000000;">operation</span></a> provides care in eight states and furnishes patients with wireless  remote devices that can check blood pressure, pulse, temperature and  other vital signs.  This data is then sent to the US Tele-Medicine EMR  platform, which is accessible to Dora, her primary physician and the  doctors at US Tele-Medicine.</p>
<p>“Why didn’t my insurance company or doctor  suggest telemedicine for me?” asked Dora, “they know I have trouble  getting around.  Now I check my blood pressure whenever I need or when  the telemedicine doctors tell me and I do it without bothering anyone or  leaving the house.”</p>
<p>The convenience factor aside, US Tele-Medicine billed her payor about  $200 for the telemedicine visit, the remote devices, and the support she  receives on line 24/7.  The difference is staggering.  Dora’s insurance  company saved about $250 &#8211; $400, Dora saved her neighborly relations,  the pain she felt when moving in and out of a vehicle, she saved on gas  money, and the four hours of time it once took, all to get her blood  pressure checked.</p>
<p>Dora is just one of the thousands of patients  enjoying the benefits of telemedicine in the USA.  While still at an  early stage of mass e-care, telemedicine and especially US Tele-Medicine  have made great strides in remote sensing of vital information and the  application of medical practices using the telephone, email and the  Internet.</p>
<p>“Our focus is on a specific patient demographic,” said Gideon Ilumin,  Director of Business Affairs for US Tele-Medicine.  “The US  Tele-Medicine business model operates at its most favorable condition  when dealing with patients who are functional human beings, but suffer  from some sort of chronic condition such as <a id="KonaLink3" href="http://www.free-press-release.com/news-telemedicine-brings-immediate-relief-1280780009.html#" target="undefined"><span style="color: #000000;">diabetes</span></a>,  obesity, allergies, even <a id="KonaLink4" href="http://www.free-press-release.com/news-telemedicine-brings-immediate-relief-1280780009.html#" target="undefined"><span style="color: #000000;">depression</span></a> and require constant medical oversight.”</p>
<p>Ilumin continued, “These people lead full  lives and the prospect of taking a day off of work or school to see a  doctor is truly bothersome, leads to unnecessary absenteeism and is  simply just expensive for everyone concerned: the employer, the patient  and the payor.</p>
<p>Telemedicine removes the majority of the expense, the bother, and the  time needed for these people to receive the care they require.  If you  are talking about rural America, then the difference, the savings and  the benefits of Telemedicine are even more dramatic.”</p>
<p>Federal departments such as Commerce, Agriculture, Defense, and of  course the HHS are funding telemedicine initiatives throughout the  country.  Most are smaller test groups or pilot ventures.</p>
<p>“Pilot programs now are a waste of time and  indicative of the continued failed health care institutional thinking.”  says Ilumin, “There have been countless of pilot studies for the past  ten years worldwide, and all of them show the same conclusive results;  patients become healthier, there is a marked decrease of  hospitalization, costs for all concerned are reduced, and more patients  receive more health care, than with any other model.”</p>
<p>Ilumin went on to say that the reason Telemedicine is slow to progress  and find acceptance  nationwide is medical communities themselves.  Each  individual institution needs original empirical data that is found  acceptable by a group of doctors, while disregarding other studies not  done by that institution, is slowing the acceptance of the Telemedicine  process.  Ilumin asked, “How often do you have to re-invent the wheel?”</p>
<p>Health insurers seem to be on the forefront of  telemedicine, more so than the medical community.  Anthem Blue Cross  has published guidelines for Telemedicine Providers in their network.   United healthcare is offering its services to Delta Airline employees,  Blue Sheild is offering Telemedicine services to its patients in the San  Fransisco bay area, and many others are launching this new product.</p>
<p>There are tens of millions of Dora Johnsons suffering chronic pain and  individuals afflicted with conditions that allow them to function, but  never live optimally.  Right now these people are a drain on themselves,  emotionally, spiritually and financially, a drain on payors who are  shelling out excess dollars for their primary care, and on the system  itself,  that lacks the presence of family and managed care physicians  for this population.</p>
<p>From all indications, the people with  life-long <a id="KonaLink5" href="http://www.free-press-release.com/news-telemedicine-brings-immediate-relief-1280780009.html#" target="undefined"><span style="color: #000000;">medical conditions</span></a> clog the medical structure, they disproportionately increase costs and  never truly seem to obtain the level of care and support required to  achieve wellness.<br />
Tele-Medicine corrects these issues, lowers costs and provides  immediate, personalized, refined and definitive health care to each  person.</p>
<p>“My life is better, no question about that.  I also feel safer and more  cared for sitting in my house, than I ever did at any doctors’ office  anywhere and the neighbors aren’t afraid to pick up my calls now.”  Dora  shares this sentiment with the thousands of US Tele-Medicine patients  who are reaching higher levels of wellness and care, without the added  bother or expense of visiting a doctor’s office.</p>
<p>Any patient may join by logging on to  www.epatienthealthcare.com and clicking the “Join Now” tab found on that  web site.  US Tele-Medicine is a leader in national telemedicine care,  founded in 2005, in network with the major carriers and serving patients  throughout the United States.</p>
<p>&#8211;end</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/08/02/telemedicine-brings-immediate-relief/feed/</wfw:commentRss>
		<slash:comments>136</slash:comments>
		</item>
		<item>
		<title>Telemedicine Touts Labor Unions to Reduce Healthcare Costs</title>
		<link>http://www.epatienthealthcare.com/blog/2010/06/23/telemedicine-touts-labor-unions-to-reduce-healthcare-costs/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/06/23/telemedicine-touts-labor-unions-to-reduce-healthcare-costs/#comments</comments>
		<pubDate>Thu, 24 Jun 2010 02:12:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Press Release]]></category>
		<category><![CDATA[chronic illness]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[employee benefits]]></category>
		<category><![CDATA[health costs]]></category>
		<category><![CDATA[health plans]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[insurance claims]]></category>
		<category><![CDATA[labor unions]]></category>
		<category><![CDATA[self insured]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[unions]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=833</guid>
		<description><![CDATA[FOR IMMEDIATE RELEASE A national leader and pioneer in Telemedicine has pitched its cost saving platform to union leaders in California, Arizona, and Nevada. Contact: Jim McMann 702-516-4047 media@ustelemedicine.com (Beverly Hills) US Tele-Medicine has pitched its cost saving telemedicine platform to union leaders in California, Arizona, and Nevada. US Tele-Medicine (www.ustelemedicine.com) claims their telemedicine based [...]]]></description>
			<content:encoded><![CDATA[<p>FOR IMMEDIATE RELEASE</p>
<p>A national leader and pioneer in Telemedicine has pitched its cost saving platform to union leaders in California, Arizona, and Nevada.</p>
<p> Contact: Jim McMann 702-516-4047 media@ustelemedicine.com</p>
<p>(Beverly Hills) US Tele-Medicine has pitched its cost saving telemedicine platform to union leaders in California, Arizona, and Nevada.</p>
<p>US Tele-Medicine (www.ustelemedicine.com) claims their telemedicine based management of chronic “lifestyle” health conditions reduces direct health care costs by 25%.</p>
<p>“Outpatient services and facility charges have risen by over 12% in 2009 and expected to rise over 11% this year,” said Gideon Ilumin, Director of Strategic Affairs for US Tele-Medicine. “Tele-Medicine means no facility charges and our physicians are Family Doctors, which means reduced medical fees.”</p>
<p>The scarcity of general medicine or family practitioners in the USA is causing medical fees to rise. There is no relief in sight as only 6% of recent medical school graduates are seeking their careers in general or family medicine. The relevance is that patients needing primary care, or general health management, are treated by specialists costing hundreds of dollars more per visit, than would be charged by a family physician.</p>
<p>To exasperate the circumstances, over 50 million Americans seek this primary care at a hospital ER. Expanded billing to unions and other self-insured entities reflects these rising facility charges, special ER fees, specialist fees and unless intervened with, this unsustainable practice will continue unabated.</p>
<p>“One of the problems,” continued Ilumin, “is that we have allowed a middleman hospital mentality to foster health care. Rather than a patient dealing directly with their physician, we established needless hurdles for the patient and redundant levels of micro-management. All of it comes at a price and at the expense of self-insured unions, companies or taxes.”<br />
Ilumin said, “Telemedicine will save any union or entity about 25% of their overall outpatient health care expenses.”</p>
<p>These are serious numbers in our current economic state and that translates to millions of additional available dollars for hiring, continued benefits, and fiscal recovery.<br />
In addition to medical costs, employees and employers benefit from the telemedicine model where workers “visit” a physician from home, or at work and not at some remote hospital or clinic. Most US companies lose 9-10 days a year of production/ income for every employee, just to visit a Doctor.</p>
<p>A company employing 2,000 workers will suffer yearly loses of about 19,000 days of no performance, so an employee can travel to a doctor. Of those office visits, 65% are for a chronic “lifestyle” health conditions, treatable by telemedicine and therefore making those office visits keenly superfluous and unwarranted in expense.</p>
<p>US Tele-Medicine e-patients are given easy-to-use consumer medical devices that monitor vital data and send that information via a wireless signal, directly into the patient’s file on the Us Tele-Medicine<br />
EMR platform. It is then reviewed by a physician, for any determination or action. Any spikes or abnormalities in the readings cause an alarm and brings immediate medical intervention.<br />
That is competent medicine. That is care in 2010 and for the immediate future.</p>
<p>US Tele-Medicine’s chronic care management system is proven to advance the health and wellness of patients and is state-of-the-art in medical care. The advanced EMR system now communicates with any records platform worldwide making the transfer of all patient files, images and records possible.</p>
<p>The modality practiced by US Tele-Medicine, brings health care to the patient, wherever the patient is, and exactly when the patient needs it. That is pure telemedicine as its optimum form, for now.</p>
<p>www.ustelemedicine.com<br />
www.epatienthealthcare.com</p>
<p>&#8212;end</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/06/23/telemedicine-touts-labor-unions-to-reduce-healthcare-costs/feed/</wfw:commentRss>
		<slash:comments>116</slash:comments>
		</item>
		<item>
		<title>Telemedicine Can Reduce Corporate Health Care Costs By 25%</title>
		<link>http://www.epatienthealthcare.com/blog/2010/06/16/telemedicine-can-reduce-corporate-health-care-costs-by-25/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/06/16/telemedicine-can-reduce-corporate-health-care-costs-by-25/#comments</comments>
		<pubDate>Thu, 17 Jun 2010 00:45:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[corporate health care costs]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[employee health care]]></category>
		<category><![CDATA[health care costs]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[lower health care costs]]></category>
		<category><![CDATA[self insured]]></category>
		<category><![CDATA[Tele-Medicine Care]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=829</guid>
		<description><![CDATA[June 16, 2010 United States of America 0 Telemedicine reduces ER visits, incidences of hospitalization, promotes better health and reduces corporate health care costs by 25%.   // // // // FOR IMMEDIATE RELEASE (Free-Press-Release.com) June 16, 2010 &#8212; Press Release Contact: James McMann, 702-516-4047 support@ustelemedicine.com For Immediate Release June 16,2010 Telemedicine Can Reduce Corporate [...]]]></description>
			<content:encoded><![CDATA[<h1></h1>
<p><a href="http://www.free-press-release.com/news/20100616/">June 16, 2010</a> <a href="http://www.free-press-release.com/news-by-country/1-1.html">United States of America</a></p>
<div>
<div>0</div>
<div>
<div><a title="Tweet This" href="http://www.addthis.com/bookmark.php?pub=fpr&amp;v=250&amp;source=tbx-250&amp;tt=0&amp;s=twitter&amp;url=http%3A%2F%2Fwww.free-press-release.com%2Fnews-telemedicine-can-reduce-corporate-health-care-costs-by-25-1276734972.html&amp;title=Telemedicine%20Can%20Reduce%20Corporate%20Health%20Care%20Costs%20By%2025%25%20-%20Free-Press-Release.com&amp;content=&amp;lng=en" target="_blank"><img alt="" /></a> <a title="Send to Facebook" href="http://www.addthis.com/bookmark.php?pub=fpr&amp;v=250&amp;source=tbx-250&amp;tt=0&amp;s=facebook&amp;url=http%3A%2F%2Fwww.free-press-release.com%2Fnews-telemedicine-can-reduce-corporate-health-care-costs-by-25-1276734972.html&amp;title=Telemedicine%20Can%20Reduce%20Corporate%20Health%20Care%20Costs%20By%2025%25%20-%20Free-Press-Release.com&amp;content=&amp;lng=en" target="_blank"><img alt="" /></a></div>
</div>
<p><script src="http://s7.addthis.com/js/250/addthis_widget.js#username=fpr" type="text/javascript"></script></div>
<h2>Telemedicine reduces ER visits, incidences of hospitalization, promotes better health and reduces corporate health care costs by 25%.</h2>
<p> <br />
 <script type="text/javascript">// <![CDATA[// <![CDATA[
google_ad_client = "pub-4140692434942764";
/* fpr3-1pr-top-468, created 4/12/10 */
google_ad_slot = "3401621084";
google_ad_width = 468;
google_ad_height = 15;
// ]]&gt;</script> <script src="http://pagead2.googlesyndication.com/pagead/show_ads.js" type="text/javascript">
</script><script src="http://pagead2.googlesyndication.com/pagead/expansion_embed.js"></script><script src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></script><script type="text/javascript">// <![CDATA[// <![CDATA[
google_protectAndRun("ads_core.google_render_ad", google_handleError, google_render_ad);
// ]]&gt;</script><ins><ins></ins></ins></p>
<div><script type="text/javascript">// <![CDATA[// <![CDATA[
google_ad_client = "pub-4140692434942764";
google_alternate_ad_url = "http://www.free-press-release.com/ads/pubarticles.html";
google_ad_width = 336;
google_ad_height = 280;
google_ad_format = "336x280_as";
google_ad_type = "text_image";
google_ad_channel = "8590001888+9259560495+8502953658";
google_color_border = "FFFFFF";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "666666";
google_color_url = "666666";
// ]]&gt;</script> <script src="http://pagead2.googlesyndication.com/pagead/show_ads.js" type="text/javascript"></script><script type="text/javascript">// <![CDATA[// <![CDATA[
google_protectAndRun("ads_core.google_render_ad", google_handleError, google_render_ad);
// ]]&gt;</script><ins><ins></ins></ins></div>
<p>FOR IMMEDIATE RELEASE<br />
(<a href="http://www.free-press-release.com/">Free-Press-Release.com</a>) June 16, 2010 &#8212;   	  Press Release</p>
<p>Contact: James McMann, 702-516-4047  support@ustelemedicine.com</p>
<p>For Immediate Release June 16,2010</p>
<p>Telemedicine Can Reduce Corporate Health Care Costs By 25%</p>
<p>(Beverly Hills) Self Insured Corporations are &#8220;avoidably&#8221; losing expensive days of production, income, and performance, because employees visit Doctors. Unfortunately, employees do fall ill from time to time and require immediate or urgent care.</p>
<p>Emergencies however are not too costly in terms of lost workdays; those are generally predictable short-term incidents. It is the days lost visiting doctors for allergies, anxiety, the cold, blood pressure, heart conditions, weight issues, diabetes, and many other &#8220;everyday lifestyle&#8221; health conditions that are chronic, which cost the most in the net loss of income, work and production.</p>
<p>A corporation employing 3,000 people will suffer a staggering 27,000 lost days of service, revenue, and performance &#8211; unnecessarily. Employees are away from work because they travel distances to <a id="KonaLink0" href="http://www.free-press-release.com/news-telemedicine-can-reduce-corporate-health-care-costs-by-25-1276734972.html#" target="undefined"><span style="color: #000000;">medical offices</span></a>, fill forms, wait, and finally, see a Doctor for five minutes. This really does require a full day off. It also generates employee frustration and anxiety. It is especially difficult for management considering not only the cost of the <a id="KonaLink1" href="http://www.free-press-release.com/news-telemedicine-can-reduce-corporate-health-care-costs-by-25-1276734972.html#" target="undefined"><span style="color: #000000;">health care</span></a>, but also the loss of time and effort.</p>
<p>US Tele-Medicine is a Family and General Practice medical provider in eight states using Telemedicine protocols and techniques, to care for employees in the comfort, safety, and privacy of their office or their home. This platform reduces out-of-work doctor office visits and days lost of income by a whopping 50%.</p>
<p>Telemedicine <a id="KonaLink2" href="http://www.free-press-release.com/news-telemedicine-can-reduce-corporate-health-care-costs-by-25-1276734972.html#" target="undefined"><span style="color: #000000;">Medical Services</span></a> costs less to any self-insured entity, simply because Family and General Medicine practitioners, charge 25% less for their services. Employers are paying excessively high prices for over qualified specialists performing basic medical tasks.</p>
<p>Corporations can save over 25% in health care costs in this new era of health connectivity through telemedicine.<br />
Telemedicine actually condenses and strengthens the interaction between patient and doctor, irrespective of how many miles away the patient might be.</p>
<p>Employees use of a variety of compact state-of-the-art consumer wireless devices allowing physicians to monitor vital data remotely, providing real time, or scheduled time, diagnostic, and management markers. Many of these devices are standardized, further savings costs as more than one individual in an office or department can use them.</p>
<p>That means an employee receives consistent quality care, becomes a more informed and involved patient, shows a reduction in emergency <a id="KonaLink3" href="http://www.free-press-release.com/news-telemedicine-can-reduce-corporate-health-care-costs-by-25-1276734972.html#" target="undefined"><span style="color: #000000;">physician services</span></a>, suffers less chronic incident peak periods, and all this means significantly less costs for all concerned.</p>
<p>Today <a id="KonaLink4" href="http://www.free-press-release.com/news-telemedicine-can-reduce-corporate-health-care-costs-by-25-1276734972.html#" target="undefined"><span style="color: #000000;">medical care</span></a> is available when you need it, when you want it, at less cost and higher efficiency. That is the Telemedicine health revolution.</p>
<p>US Tele-Medicine Patient Web Site: http://www.epatienthealthcare.com</p>
<p>US Tele-Medicine Corporate Web Sitehttp://www.ustelemedicine.com</p>
<p>END -</p>
<p>More information can be found online at <a name="1276734972" rel="nofollow" href="http://www.ustelemedicine.com/" target="_blank"><span style="text-decoration: underline;">http://www.ustelemedicine.com</span></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/06/16/telemedicine-can-reduce-corporate-health-care-costs-by-25/feed/</wfw:commentRss>
		<slash:comments>213</slash:comments>
		</item>
		<item>
		<title>Alternative Medicine for Treating Cancer</title>
		<link>http://www.epatienthealthcare.com/blog/2010/05/12/alternative-medicine-for-treating-cancer/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/05/12/alternative-medicine-for-treating-cancer/#comments</comments>
		<pubDate>Wed, 12 May 2010 07:38:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Herbs]]></category>
		<category><![CDATA[Homeopathic]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Nutritional Blends]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[chronic pain]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[E-Care Plan]]></category>
		<category><![CDATA[herbal supplements]]></category>
		<category><![CDATA[holistic]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[insurance claims]]></category>
		<category><![CDATA[lifestyle health]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[Tele-Medicine]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=726</guid>
		<description><![CDATA[Cancer is the name given to any illness resulting from one of our body’s own cells growing out of control. There are many processes that control a cell’s growth and division, each of which can go wrong. Several of these control mechanisms need to be damaged before a cell becomes cancerous. There are more than [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Cancer is the name given to any illness resulting from one of our body’s own cells growing out of control. There are many processes that control a cell’s growth and division, each of which can go wrong. Several of these control mechanisms need to be damaged before a cell becomes cancerous. There are more than 200 different types of cancers, which are categorized in to carcinoma, sarcoma, lymphoma and leukemia based on the cells from which they arise.</strong></p>
<p><strong>The principles involved in treating cancer are either directly destroying the cancer tissues or indirectly destroying them by depriving them of blood supply and/or their nutrition. But the irony is that whatever conventional treatment is used to destroy cancer cells do affect to some extent the normal cells also. They may damage the skin, liver, intestine the bone marrow and other rapidly multiplying cells. Sometimes the effect of the treatment is more devastating than the disease itself.</strong></p>
<p><strong>Role of Alternative Medicine in treating cancer</p>
<p>A larger study of Alternative medicine use in patients with different types of cancer was published in the July 2000 issue of the Journal of Clinical Oncology. It was found that nearly 70% of the patients used at least one form alternative medicine along with the conventional treatment. The National Cancer Institute (NCI) and the National Center for Complementary and Alternative Medicine (NCCAM) are sponsoring a number of clinical trials at medical centers to evaluate alternative medical therapies for cancer.</strong></p>
<p><strong>Alternative medicine includes therapies like herbal remedies, vitamins, special diets, and acupuncture among others.</p>
<p>Acupuncture: effective in the management of chemotherapy associated nausea and vomiting and in controlling pain associated with surgery. Now used in a trial to reduce the symptoms of colorectal cancer</strong></p>
<p><strong>The Budwig Diet &#8211; Protocol</strong></p>
<p><strong>Homeopathy</p>
<p>-Ayurveda</p>
<p>-Shark cartilage: Being tried in non-small cell lung cancer. it prevents new blood vessels growth</p>
<p>-Hyperbaric oxygen: In patients who had larynx removed for larynx cancer</p>
<p>-Massage therapy: for cancer related fatigue</p>
<p>-Pancreatic enzyme therapy along with specialized diet for the treatment of pancreatic cancer</p>
<p>-Mistletoe extract: for the treatment of solid tumors</p>
<p>-Wheatgrass therapy</p>
<p>-Macrobiotics: The macrobiotic diet is strictly vegetarian and requires you to consume about half of your daily calories from whole grains, about a quarter of your calories from vegetables, and the rest of your calories from beans, seaweed and soups</p>
<p>-Bioelectric therapies</p>
<p>-Moerman’s Anti-Cancer diet</p>
<p>-Hoxsey herbal therapy</p>
<p>-Essiac herbal therapy: Essiac is a herbal tea mixture that relieves pain and reduces the size of tumors. It contains four herbs- burdock, rhubarb, sheep sorrel and slippery elm</p>
<p>-Pau D’Arco herbal therapy</p>
<p>-Chaparral herbal therapy</p>
<p>-Laetrile (amygdalin): a chemical found in lima beans, raw nuts and the pits of many fruits. Amygdalin produces cyanide, which proponents claim kills cancer</p>
<p>-Alkaline diet: such as fruits and vegetables and restricting acidic foods</p>
<p>-Antioxidant found in fruits and vegetables</p>
<p>-Vitamins A, C and E: These are very good anti oxidants</p>
<p>-Detox therapies including Gonzales nutritional metabolic therapy, colon therapy, and Gerson therapy</p>
<p>The most successful practitioners integrate various components of the alternative cancer treatments for a better outcome.</strong></p>
<p><strong> </strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/05/12/alternative-medicine-for-treating-cancer/feed/</wfw:commentRss>
		<slash:comments>439</slash:comments>
		</item>
		<item>
		<title>Cognition Improved By Mindfulness Meditation</title>
		<link>http://www.epatienthealthcare.com/blog/2010/05/10/cognition-improved-by-mindfulness-meditation/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/05/10/cognition-improved-by-mindfulness-meditation/#comments</comments>
		<pubDate>Tue, 11 May 2010 02:34:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Human Behavior]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[chronic pain]]></category>
		<category><![CDATA[E-Care]]></category>
		<category><![CDATA[E-Care Plan]]></category>
		<category><![CDATA[health. healthcare]]></category>
		<category><![CDATA[herbal supplements]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Medical Studies]]></category>
		<category><![CDATA[refunds for vitamins]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/?p=715</guid>
		<description><![CDATA[Some of us need regular amounts of coffee or other chemical enhancers to make us cognitively sharper. A newly published study suggests perhaps a brief bit of meditation would prepare us just as well. While past research using neuroimaging technology has shown that meditation techniques can promote significant changes in brain areas associated with concentration, [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Some of us need regular amounts of coffee or other chemical enhancers to make us cognitively sharper. A newly published study suggests perhaps a brief bit of meditation would prepare us just as well.</p>
<p>While past research using neuroimaging technology has shown that meditation techniques can promote significant changes in brain areas associated with concentration, it has always been assumed that extensive training was required to achieve this effect. Though many people would like to boost their cognitive abilities, the monk-like discipline required seems like a daunting time commitment and financial cost for this benefit.</p>
<p>Surprisingly, the benefits may be achievable even without all the work. Though it sounds almost like an advertisement for a &#8220;miracle&#8221; weight-loss product, new research now suggests that the mind may be easier to cognitively train than we previously believed. Psychologists studying the effects of a meditation technique known as &#8220;mindfulness &#8221; found that meditation-trained participants showed a significant improvement in their critical cognitive skills (and performed significantly higher in cognitive tests than a control group) after only four days of training for only 20 minutes each day.</p>
<p>&#8220;In the behavioral test results, what we are seeing is something that is somewhat comparable to results that have been documented after far more extensive training,&#8221; said Fadel  Zeidan, a post-doctoral researcher at Wake Forest University School of Medicine, and a former doctoral student at the University of North Carolina at Charlotte, where the research was conducted.</p>
<p>&#8220;Simply stated, the profound improvements that we found after just 4 days of meditation training are really surprising,&#8221; Zeidan noted. &#8220;It goes to show that the mind is, in fact, easily changeable and highly influenced, especially by meditation.&#8221;</p>
<p>The study appears in the April 2 issue of Consciousness and Cognition. Zeidan&#8217;s co-authors are Susan K. Johnson, Zhanna David and Paula Goolkasian from the Department of Psychology at UNC Charlotte, and Bruce J. Diamond from William Patterson University. The research was also part of Zeidan&#8217;s doctoral dissertation. The research will also be presented at the Cognitive Neuroscience Society&#8217;s annual meeting in Montreal, April 17-20.</p>
<p>The experiment involved 63 student volunteers, 49 of whom completed the experiment. Participants were randomly assigned in approximately equivalent numbers to one of two groups, one of which received the meditation training while the other group listened for equivalent periods of time to a book (J.R.R. Tolkein&#8217;s The Hobbit) being read aloud.</p>
<p>Prior to and following the meditation and reading sessions, the participants were subjected to a broad battery of behavioral tests assessing mood, memory, visual attention, attention processing, and vigilance.</p>
<p>Both groups performed equally on all measures at the beginning of the experiment. Both groups also improved following the meditation and reading experiences in measures of mood, but only the group that received the meditation training improved significantly in the cognitive measures. The meditation group scored consistently higher averages than the reading/listening group on all the cognitive tests and as much as ten times better on one challenging test that involved sustaining the ability to focus, while holding other information in mind.</p>
<p>&#8220;The meditation group did especially better on all the cognitive tests that were timed,&#8221; Zeidan noted. &#8220;In tasks where participants had to process information under time constraints causing <a title="What Is Stress? How To Deal With Stress" rel="nofollow" href="http://www.medicalnewstoday.com/articles/145855.php">stress</a>, the group briefly trained in mindfulness performed significantly better.&#8221;</p>
<p>Particularly of note were the differing results on a &#8220;computer adaptive n-back task,&#8221; where participants would have to correctly remember if a stimulus had been shown two steps earlier in a sequence. If the participant got the answer right, the computer would react by increasing the speed of the subsequent stimulus, further increasing the difficulty of the task. The meditation-trained group averaged aproximately10 consecutive correct answers, while the listening group averaged approximately one.</p>
<p>&#8220;Findings like these suggest that meditation&#8217;s benefits may not require extensive training to be realized, and that meditation&#8217;s first benefits may be associated with increasing the ability to sustain attention,&#8221; Zeidan said.</p>
<p>&#8220;Further study is warranted,&#8221; he stressed, noting that brain imaging studies would be helpful in confirming the brain changes that the behavioral tests seem to indicate, &#8220;but this seems to be strong evidence for the idea that we may be able to modify our own minds to improve our cognitive processing &#8211; most importantly in the ability to sustain attention and vigilance &#8211; within a week&#8217;s time.&#8221;</p>
<p>The meditation training involved in the study was an abbreviated &#8220;mindfulness&#8221; training regime modeled on basic &#8220;Shamatha skills&#8221; from a Buddhist meditation tradition, conducted by a trained facilitator. As described in the paper, &#8220;participants were instructed to relax, with their eyes closed, and to simply focus on the flow of their breath occurring at the tip of their nose. If a random thought arose, they were told to passively notice and acknowledge the thought and to simply let &#8216;it&#8217; go, by bringing the attention back to the sensations of the breath.&#8221; Subsequent training built on this basic model, teaching physical awareness, focus, and mindfulness with regard to distraction.</p>
<p>Zeidan likens the brief training the participants received to a kind of mental calisthenics that prepared their minds for cognitive activity.</p>
<p>&#8220;The simple process of focusing on the breath in a relaxed manner, in a way that teaches you to regulate your emotions by raising one&#8217;s awareness of mental processes as they&#8217;re happening is like working out a bicep, but you are doing it to your brain. Mindfulness meditation teaches you to release sensory events that would easily distract, whether it is your own thoughts or an external noise, in an emotion-regulating fashion. This can lead to better, more efficient performance on the intended task.&#8221;</p>
<p>&#8220;This kind of training seems to prepare the mind for activity, but it&#8217;s not necessarily permanent,&#8221; Zeidan cautions. &#8220;This doesn&#8217;t mean that you meditate for four days and you&#8217;re done &#8211; you need to keep practicing.&#8221;</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/05/10/cognition-improved-by-mindfulness-meditation/feed/</wfw:commentRss>
		<slash:comments>17</slash:comments>
		</item>
		<item>
		<title>Asthma/Allergy Trigger Control Plan</title>
		<link>http://www.epatienthealthcare.com/blog/2010/03/12/asthmaallergy-trigger-control-plan/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/03/12/asthmaallergy-trigger-control-plan/#comments</comments>
		<pubDate>Sat, 13 Mar 2010 01:12:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Nutritional Blends]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[]]></category>
		<category><![CDATA[acupuncture]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[asthma]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[chronic pain]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[diet]]></category>
		<category><![CDATA[E-Care Plan]]></category>
		<category><![CDATA[E-Patients]]></category>
		<category><![CDATA[fibromyalgia]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[health. healthcare]]></category>
		<category><![CDATA[Heart Nutrition]]></category>
		<category><![CDATA[herbal supplements]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Internet]]></category>
		<category><![CDATA[Reimbursement]]></category>
		<category><![CDATA[supplements]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>
		<category><![CDATA[vitamins, supplements]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/2010/03/12/asthmaallergy-trigger-control-plan/</guid>
		<description><![CDATA[Because you have asthma, your airways are very sensitive. They may react to things called triggers (stimuli that can cause asthma episodes). Your airways may become swollen, tighten up, and produce excess mucus in the presence of one or more of the triggers below. These triggers may make asthma symptoms worse or keep you from [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">Because you have asthma, your airways are very sensitive. They may react to things called triggers (stimuli that can cause asthma episodes). Your airways may become swollen, tighten up, and produce excess mucus in the presence of one or more of the triggers below. These triggers may make asthma symptoms worse or keep you from getting better. It’s important to find out what your asthma triggers are. Learn ways to avoid them. If you cannot avoid triggers, and your medicine plan does not work as well as you and your health care provider think it should, you both should discuss allergy shots (immunotherapy).</p>
<p class="MsoNormal">Ask your health care provider to help you find out what your triggers are and to decide which actions will help the most to reduce your asthma symptoms.</p>
<p class="MsoNormal"><span> </span>Number each action item in order of importance. Carry out these actions first.</p>
<p class="MsoNormal">Once you have completed these actions, move on to actions that are of lesser importance.</p>
<p class="MsoNormal">Discuss the results of these efforts with your health care provider.</p>
<p class="MsoNormal"><strong><em>Pollen and Molds (outdoors)<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Stay indoors during the midday and afternoon when the pollen count is high.</p>
<p class="MsoNormal"><span> </span>Use air conditioning, if possible.</p>
<p class="MsoNormal"><span> </span>Keep windows closed during seasons when pollen and mold are highest.</p>
<p class="MsoNormal"><span> </span>Avoid sources of molds (wet leaves, garden debris, carpet over concrete floors).</p>
<p class="MsoNormal"><strong><em>Cockroach Allergen<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Use insect sprays; but have someone else spray when you are outside of the home.</p>
<p class="MsoNormal"><span> </span>Air out the home for a few hours after spraying.</p>
<p class="MsoNormal"><span> </span>Use roach traps.</p>
<p class="MsoNormal"><strong><em>House Dust Mites<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span>These are actions you should take to<o:p></o:p></span></p>
<p class="MsoNormal"><span>gain control of dust mites:<o:p></o:p></span></p>
<p class="MsoNormal">______ Encase your mattress and box spring in an airtight cover.</p>
<p class="MsoNormal">______ Either encase your pillow or wash it once a week every week.</p>
<p class="MsoNormal">______ Avoid sleeping or lying on upholstered furniture.</p>
<p class="MsoNormal">______ Remove carpets that are laid on concrete.</p>
<p class="MsoNormal">______ Wash your bed covers, clothes, and stuffed toys once a week in hot (130° F) water.</p>
<p class="MsoNormal"><strong><em>These actions will also help you gain control of dust mites &#8211; but they may not be<o:p></o:p></em></strong></p>
<p class="MsoNormal"><strong><em>essential:<o:p></o:p></em></strong></p>
<p class="MsoNormal">______ Reduce indoor humidity to less than 50 percent. Use a dehumidifier if needed.</p>
<p class="MsoNormal">______ Remove carpets from your bedroom.</p>
<p class="MsoNormal">______ Use chemical agents to kill mites or to change mite antigens in the house.</p>
<p class="MsoNormal">______ Avoid using a vacuum or being in a room while it is being vacuumed.</p>
<p class="MsoNormal">______ If you must vacuum, one ore more of the following things can be done to reduce the amount of dust you breathe in: Use a dust mask, use a central vacuum cleaner with the collecting bag outside the home, use a vacuum cleaner that has powerful suction.</p>
<p class="MsoNormal"><strong><em>Animal Dander<o:p></o:p></em></strong></p>
<p class="MsoNormal">Dander refers to flakes in the skin, hair, or feathers of all warm-blooded pets including dogs, cats, birds, and rodents. There is no such thing as an allergenfree dog. The length of a pet’s hair does not matter. The allergen is in the saliva, urine, and dander.</p>
<p class="MsoNormal"><span> </span>Remove the animal from the house or school classroom.</p>
<p class="MsoNormal"><span> </span>If you must have a pet, keep the pet out of your bedroom at all times.</p>
<p class="MsoNormal"><span> </span>If there is forced air heating in the home with a pet, close the air ducts in your bedroom.</p>
<p class="MsoNormal"><span> </span>Wash the pet weekly.</p>
<p class="MsoNormal"><span> </span>Avoid visits to friends or relatives with pets.</p>
<p class="MsoNormal"><span> </span>Take asthma medicine (cromolyn or beta2-agonist; cromolyn is often preferred) before</p>
<p class="MsoNormal">visiting homes or sites where animals arepresent.</p>
<p class="MsoNormal">Choose a pet without fur or feathers (such as a fish or a snake).</p>
<p class="MsoNormal"><span> </span>Avoid products made with feathers, for example, pillows or comforters.</p>
<p class="MsoNormal"><span> </span>Also avoid pillows, bedding, and furniture stuffed with kapok (silky fibers from the seed</p>
<p class="MsoNormal">pods of the silk-cotton tree).</p>
<p class="MsoNormal">Use a vacuum cleaner fitted with a HEPA (high-efficiency particulate air) filter.</p>
<p class="MsoNormal"><strong><em>Indoor molds<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Keep bathrooms, kitchens, and basements well aired.</p>
<p class="MsoNormal"><span> </span>Clean bathrooms, kitchens, and basements regularly.</p>
<p class="MsoNormal"><span> </span>Do not use humidifiers unless humidity drops below 15%</p>
<p class="MsoNormal"><span> </span>Use dehumidifiers for damp basement areas, with humidity level set for less than</p>
<p class="MsoNormal">50% but above 25%. Empty and clean unit regularly.</p>
<p class="MsoNormal"><strong><em>Tobacco Smoke<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Do not smoke.</p>
<p class="MsoNormal"><span> </span>Do not allow smoking in the home.</p>
<p class="MsoNormal"><span> </span>Have household members smoke outside.</p>
<p class="MsoNormal"><span> </span>Do not allow any smoking in your bedroom.</p>
<p class="MsoNormal">Encourage family members to quit smoking.</p>
<p class="MsoNormal">Their health care provider can help them quit.</p>
<p class="MsoNormal"><span> </span>Use an indoor air-cleaning device (for smoke, mold, and dander).</p>
<p class="MsoNormal"><strong><em>Wood Smoke<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Avoid using a wood burning heat stove to heat your home. The smoke increases</p>
<p class="MsoNormal">lower respiratory symptoms.</p>
<p class="MsoNormal"><span> </span>Avoid using kerosene heaters.</p>
<p class="MsoNormal"><strong><em>Strong Odors and Sprays<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Do not stay in your home when it is being painted. Allow enough time for the paint</p>
<p class="MsoNormal">to dry.</p>
<p class="MsoNormal"><span> </span>Avoid perfume and perfumed cosmetics such as talcum powder and hair spray.</p>
<p class="MsoNormal"><span> </span>Do not use room deodorizers. § Use non-perfumed household cleaning</p>
<p class="MsoNormal">products whenever possible.</p>
<p class="MsoNormal"><span> </span>Reduce strong cooking odors (especially frying) by using a fan and opening windows.</p>
<p class="MsoNormal"><span> </span>Avoid air pollution by staying indoors on days when the pollution count is high.</p>
<p class="MsoNormal"><strong><em>Colds and Infections<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Avoid people with colds or the flu.</p>
<p class="MsoNormal"><span> </span>Get rest, eat a balanced diet, and exercise regularly.</p>
<p class="MsoNormal"><span> </span>Talk to your health care provider about flu shots.</p>
<p class="MsoNormal"><span> </span>Do not take over-the-counter remedies, such as antihistamines and cough syrup,</p>
<p class="MsoNormal">unless you speak to your health care provider first.</p>
<p class="MsoNormal"><strong><em>Exercise<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Work out a medicine plan with your health care provider that allows you to exercise</p>
<p class="MsoNormal">without symptoms.</p>
<p class="MsoNormal"><span> </span>Take inhaled beta2-agonist or prescribed anti-inflammatory medicine before</p>
<p class="MsoNormal">exercising.</p>
<p class="MsoNormal"><span> </span>Warm up before doing exercise and cool down afterwards.</p>
<p class="MsoNormal"><strong><em>Weather<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>Wear a scarf over your mouth and nose in cold weather.</p>
<p class="MsoNormal"><span> </span>Pull a turtleneck over your nose on windy or cold days.</p>
<p class="MsoNormal"><span> </span>Dress warmly in the winter or on windy days.</p>
<p class="MsoNormal"><strong><em>Food Sensitivity<o:p></o:p></em></strong></p>
<p class="MsoNormal"><span> </span>You may want to avoid products that could possibly contain the preservative sulfite.</p>
<p class="MsoNormal">Among these are: precut or dried fruit, fresh mushrooms, processed potatoes, pickled</p>
<p class="MsoNormal">foods, shrimp, cherries , beer, or wine.</p>
<p class="MsoNormal"><strong>Remember: </strong>Making these changes will help keep asthma episodes from starting. An asthma trigger control plan is an important part of controlling asthma</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/03/12/asthmaallergy-trigger-control-plan/feed/</wfw:commentRss>
		<slash:comments>303</slash:comments>
		</item>
		<item>
		<title>Seaweed Extract Hold Promise For Non-Hodgkin&#8217;s Lymphoma</title>
		<link>http://www.epatienthealthcare.com/blog/2010/03/12/seaweed-extract-hold-promise-for-non-hodgkins-lymphoma/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/03/12/seaweed-extract-hold-promise-for-non-hodgkins-lymphoma/#comments</comments>
		<pubDate>Sat, 13 Mar 2010 00:16:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Herbs]]></category>
		<category><![CDATA[Homeopathic]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Nutritional Blends]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[E-Care Plan]]></category>
		<category><![CDATA[E-Patients]]></category>
		<category><![CDATA[health. healthcare]]></category>
		<category><![CDATA[herbal supplements]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Internet]]></category>
		<category><![CDATA[LYMPHOMA]]></category>
		<category><![CDATA[natural health]]></category>
		<category><![CDATA[Reimbursement]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[US Telemedicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/2010/03/12/seaweed-extract-hold-promise-for-non-hodgkins-lymphoma/</guid>
		<description><![CDATA[BERKELY &#8211; Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research. Lymphoma is a cancer of the immune system and is classified into Hodgkin&#8216;s and non-Hodgkin&#8217;s types, which are then further classified into B-cell and T-cell groups. [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" /><o:smarttagtype namespaceuri="urn:schemas:contacts" name="Sn"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="GivenName"></o:smarttagtype>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object  classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object><br />
<style> st1\:*{behavior:url(#ieooui) } </style>
<p> <![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">BERKELY &#8211; Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research.<o:p></o:p></p>
<p class="MsoNormal">Lymphoma is a cancer of the immune system and is classified into <st1:sn w:st="on">Hodgkin</st1:sn>&#8216;s and non-Hodgkin&#8217;s types, which are then further classified into B-cell and T-cell groups.<o:p></o:p></p>
<p class="MsoNormal">&#8220;Some forms of B-cell lymphoma are especially resistant to standard treatment and thus new therapies are needed,&#8221; said Mohammad Irhimeh, Ph.D., assistant professor of hematoncology and stem cells at the Hashemite University in <st1:givenname w:st="on">Jordan</st1:givenname>. &#8220;In this study, we looked at a new treatment strategy using novel active compounds derived from a natural source seaweed.&#8221;<o:p></o:p></p>
<p class="MsoNormal">Seaweeds containing fucoidan, a sulfated polysaccharide similar to heparin in chemical structure, have been reported to have anti-tumor activity in mice and some cell lines.<o:p></o:p></p>
<p class="MsoNormal">For the current study, Irhimeh and colleagues at the University of California, Berkeley, and Royal Hobart Hospital in Australia treated lymphoma cell lines with a commercially available seaweed extract.<o:p></o:p></p>
<p class="MsoNormal">They found that the extract had an inhibitory effect on the growth of lymphoma cell lines, while leaving the control healthy cells intact. The researchers also noted a significant pattern of activity in the genes known to be linked with apoptosis, or cell death, in lymphoma.<o:p></o:p></p>
<p class="MsoNormal">Irhimeh said they would continue to study the mechanism of action for these biological effects and had a goal of conducting phase II or III clinical trials.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/03/12/seaweed-extract-hold-promise-for-non-hodgkins-lymphoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Are the Advantages of Alternative Cures</title>
		<link>http://www.epatienthealthcare.com/blog/2010/03/02/what-are-the-advantages-of-alternative-cures/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/03/02/what-are-the-advantages-of-alternative-cures/#comments</comments>
		<pubDate>Tue, 02 Mar 2010 20:33:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Herbs]]></category>
		<category><![CDATA[Homeopathic]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Longevity]]></category>
		<category><![CDATA[Nutritional Blends]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[cures]]></category>
		<category><![CDATA[E-Care Plan]]></category>
		<category><![CDATA[herbal mediicne]]></category>
		<category><![CDATA[herbal supplements]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Internet]]></category>
		<category><![CDATA[Reimbursement]]></category>
		<category><![CDATA[relaxation]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>
		<category><![CDATA[vitamins, supplements]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/2010/03/02/what-are-the-advantages-of-alternative-cures/</guid>
		<description><![CDATA[There are a number of advantages when it comes to alternative cures and health. This particular science and focus holds the ultimate belief that health involves many different components all in one. It focuses on encouraging individuals to carefully explore all of their options and choose many different methods to completely optimize their health. Throughout [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">There are a number of advantages when it comes to alternative cures and health. This particular science and focus holds the ultimate belief that health involves many different components all in one. It focuses on encouraging individuals to carefully explore all of their options and choose many different methods to completely optimize their health. Throughout this article, we will be exploring the many different advantages associated with alternative cures. If you have been considering a natural and effective approach to health, you may find interest in the information contained here.<o:p></o:p></p>
<p class="MsoNormal">There are many different branches when it comes to alternative medicine. You have Chinese medicine, acupuncture, homeopathy, naturopathy, guided imagery, relaxation techniques, herbal medicine, massage therapy, and other types of medicine. If we were to examine alternative medicine closely, we would see that most of the alternative options available today have actually emerged from European countries throughout history. Individuals who took an interest in medicine would study under the assistance of an elder in order to learn alternative forms of health and apply it when needed. As time progressed, these students of medicine would eventually be given a student to apprentice under them.<o:p></o:p></p>
<p class="MsoNormal">Many of the concepts that we are familiar with and focus on today that are directly related to health have emerged from the studies and the popular teaching of those who practiced alternative medicine in history. There was a particular health movement that spawned interest in water therapy or hydrotherapy, natural and essential hygiene, herbalism, and similar approaches to optimizing the health. Now that we can see what types of things emerged from a period in time in which alternative health was a popular subject, we will now examine these a bit more closely.<o:p></o:p></p>
<p class="MsoNormal">Chinese Medicine – The Chinese believed that when an individual experienced sickness, it was a direct result of a negative flow or a disruption in the flow of energy that occurs within the body. Many have seen and heard of the Yin and Yang. This represents an even distribution of energy in the body. The Chinese would use a number of techniques, like herbalism, massage therapy, acupuncture, and similar natural remedies in order to evenly distribute energy throughout the body for healing.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Acupuncture – This is the process in which fine, tiny needles are inserted in the body at specific points. It is ultimately believed that by activating or stimulating these areas of the body that one experience optimal health.<o:p></o:p></p>
<p class="MsoNormal">Homeopathy – This is a type of alternative medicine that focuses on introducing the body to many different types of natural medicine in order to encourage the body to heal itself.<o:p></o:p></p>
<p class="MsoNormal">Naturopathy – This form of alternative medicine focuses on the belief that many different things should come together in order to completely optimize the health of an individual. Ensuring the proper diet is ingested, stress management, hydrotherapy, exercise, and even herbal medicine all play an important role in the area of naturopathy.<o:p></o:p></p>
<p class="MsoNormal">Guided Imagery – This form of alternative medicine believes that if an individual learns to relax based on certain mental images that they will be able to ultimately optimize their health.<o:p></o:p></p>
<p class="MsoNormal">Relaxation Techniques – By using relaxation techniques, individuals are able to effectively control their breathing and other essential processes of the body. This can be extremely successful in creating health.<o:p></o:p></p>
<p class="MsoNormal">Herbal Medicine – Herbal medicine takes various natural plants and uses them to promote good health.<o:p></o:p></p>
<p class="MsoNormal">Massage Therapy – Massage therapy believes that by employing the element of massage on different areas of the body, circulation is improved and the health is enhanced.<o:p></o:p></p>
<p class="MsoNormal">As you can see, there are many different types of alternative medicine, all of which have a unique set of advantages for the health. If you are interested in natural medicine, all of these techniques can be employed or just one.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/03/02/what-are-the-advantages-of-alternative-cures/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Read This Before Vaccinating Your Child</title>
		<link>http://www.epatienthealthcare.com/blog/2010/03/02/read-this-before-vaccinating-your-child/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/03/02/read-this-before-vaccinating-your-child/#comments</comments>
		<pubDate>Tue, 02 Mar 2010 17:56:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Human Behavior]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Odd Medical Practices]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[austism]]></category>
		<category><![CDATA[brain]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[E-Care Plan]]></category>
		<category><![CDATA[emotional stress]]></category>
		<category><![CDATA[emotional trauma]]></category>
		<category><![CDATA[health. healthcare]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[mercury]]></category>
		<category><![CDATA[natural health]]></category>
		<category><![CDATA[nerve poison]]></category>
		<category><![CDATA[Reimbursement]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[thimerosal]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/2010/03/02/read-this-before-vaccinating-your-child/</guid>
		<description><![CDATA[One in four U.S. parents believes some vaccines cause autism in healthy children according to the Associated Press at the end of February 2010. The federal government disputes heavily this idea, so much so that it denigrates these parents and ignores the medical science that suggests a strong association between the nerve poison Thimerosal and [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" /><o:smarttagtype namespaceuri="urn:schemas:contacts" name="title"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="middlename"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="nameSuffix"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PersonName"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="GivenName"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="Sn"></o:smarttagtype>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object  classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object><br />
<style> st1\:*{behavior:url(#ieooui) }st2\:*{behavior:url(#ieooui) } </style>
<p> <![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">One in four U.S. parents believes some vaccines cause autism in healthy children according to the Associated Press at the end of February 2010. The federal government disputes heavily this idea, so much so that it denigrates these parents and ignores the medical science that suggests a strong association between the nerve poison Thimerosal and neurological impairment<o:p></o:p></p>
<p class="MsoNormal">It is a closed case as far as the medical officials are concerned as stupid as that might sound. The former Chairman of the National Institute of Health (NIH) <st2:personname w:st="on"><st1:title w:st="on">Dr.</st1:title>  <st1:givenname w:st="on">Bernadine</st1:givenname> <st1:sn w:st="on">Healy</st1:sn></st2:personname> does not agree saying, “The question has not been answered.” The Institute of Medicine’s (IOM) 2004 report on thimerosal and autism even stated, “The committee cannot rule out, based on the epidemiological evidence, the possibility that vaccines contribute to autism in some small subset or very unusual circumstances.”<o:p></o:p></p>
<p class="MsoNormal">Some doctors are taking a tough stand, asking vaccine-refusing parents to find other doctors and calling such parents &#8220;selfish.&#8221; A statement from a group practice near Philadelphia outlines its doctors’ adamant support for government recommended vaccines and their belief that &#8220;vaccines do not cause autism or other developmental disabilities.&#8221; Doctors routinely take these stances though the former head of the American Academy of Pediatrics, <st2:personname w:st="on"><st1:title w:st="on">Dr.</st1:title>  <st1:givenname w:st="on">Louis</st1:givenname> <st1:sn w:st="on">Cooper</st1:sn></st2:personname> says, “There’s been grossly insufficient investment in research on the safety of immunization.”<o:p></o:p></p>
<p class="MsoNormal">It has taken us a long time to appreciate the fact that we are wasting time arguing with the government; it has not done anyone any good. We might as well argue with a heavily armed robber or psychopath, serial killer or terrorist none of whom even have the capacity or motive to listen. People and institutions with no ‘heart’ can not be reasoned with and should be avoided like the plague. Governments are the real plague and are a pandemic even up to the level of attacking our precious babies with injectable neurological poisons.<o:p></o:p></p>
<p class="MsoNormal">I would like to offer a way for doctors to redeem their credibility in the face of their peers, their professional organizations, humanity and God on at least on one important issue that is cracking the foundations and integrity of contemporary medicine. We are dealing with soul issues here because we are talking about the deliberate injection of newborns, children, and adults with the third most toxic substance known to man and that is mercury. Mercury is the most toxic non-radioactive element on Earth, and The World Health Organization said that there are no levels of mercury that can be considered safe.<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">Everyone in the United States over the age of six<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">months should get seasonal influenza vaccines every<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">year, federal vaccine advisers said on February 25, 2010.<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt"><o:p> </o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt">All forms of organic mercury cross the blood-brain barrier easily, probably due to formation of a complex with the amino acid cysteine. It is eliminated from the organism slowly, therefore it has tendency to bioaccumulate. In the form of dimethylmercury a sniff can kill you. Anyone who listens to any justification of the practice of injecting organic mercury into babies should have their head seriously examined just the same as if they were justifying child sexual abuse (which some psychologists most incredulously have).<o:p></o:p></p>
<p class="MsoNormal">Danger! Poison! May be fatal if inhaled, absorbed through skin or swallowed. Contains material which may cause damage to the following organs: kidneys, respiratory tract, skin, eyes, central nervous system.<span>  </span>Section 8 – Exposure Controls: Personal Protection: Splash goggles, Full suit, Dust Respirator, Boots, Gloves, a self-contained breathing apparatus. Section 11 – Toxicology Information: Acute Oral Toxicity. Extremely hazardous in case of skin contact. May be fatal if absorbed. Extremely hazardous in case of inhalation. May be fatal if inhaled. Extremely hazardous in case of ingestion. May be fatal if swallowed.<span>  </span>Danger of cumulative effects.<o:p></o:p></p>
<p class="MsoNormal">What I am proposing is a clear declaration to the governments and medical boards around the world that we doctors and health care professionals will recommend to all our patients that they immediately reject and refuse all vaccinations until every government and medical body eliminates “all” use of the highly toxic vaccine preservative Thimerosal, which is fifty percent methyl-mercury by weight. We would not recommend to our patients that they drive around in a car with defective breaks or a sticking accelerator one more day nor should we let our patients remain ignorant of the dangers of Thimerosal. We need to collectively back government, health, and medical official’s backs against a hard wall giving them not a millimeter to sleaze away.<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">Mercury was taken out of animal vaccines 20 years ago<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">because it was too toxic, so why I ask my peers are<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">we allowing it to continue to be given to babies?</p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center"><o:p> </o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt">We have been deaf, dumb and blind to what is happening in the area of childhood vaccination, meaning we are allowing our medical colleagues to get away with murder and we are all guilty by implication. There are certain constraints or lines that must not be crossed and one is the injection of a cross and bones poison. If we support such medically insane and barbarous practices we should sign a form stating we agree with the principles and practices of the Nazi doctors who routinely injected medical subjects with lethal injections for experimental purposes. No one can say that vaccines don’t kill children for they do that all the time in what is officially known as “rare” occurrences.<o:p></o:p></p>
<p class="MsoNormal">There is no sitting on the fence on this issue either you support and favor the injections of poison into babies and people or you do not. It is black and white though those who think in grey shout the loudest and have most of the bullhorns in the public arena. 15% of women in America (Rh Neg) get Rhogam Thimerosal laden shots and have 50% of autistic children. If a woman has 10 or more mercury dental fillings, her chances of having an autistic child go up 27%. Boys get autism 4 to 1 more than girls. When they put mercury in Petri dishes with brain cells they get 40% cell death. Estrogen and mercury in Petri dishes somehow protected cells for only a 3% cell death. Testosterone &amp; mercury yields 100% cell death.<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">Thimerosal-preserved vaccines are significant causal factors in<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">the development of regressive neuro-developmental disorders<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center">including autism and related disorders/syndromes/diseases.<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center"><st2:personname w:st="on"><st1:title w:st="on">Dr.</st1:title>  <st1:givenname w:st="on">Paul</st1:givenname> <st1:sn w:st="on">King</st1:sn></st2:personname></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center" align="center"><o:p> </o:p></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt">A review of medical literature indicates that the characteristics of autism and of mercury poisoning (HgP) are strikingly similar. The parallels between the two diseases are so thorough as to suggest, based on total Hg injected into U.S. children, that many cases of autism are a form of mercury poisoning. Professor John Oxford of Queen Mary’s School of Medicine and Dentistry states: From Alzheimer’s disease to a devastating lineup of other neurological disorders including Parkinsons, ALS, MS, autism and AD – mercury is known to be a potent neurotoxin that either is the prime cause of such disorders or certainly is seen to exacerbate them. He says, “If there is &#8220;any doubt whatsoever&#8221; about the safety of mercury in vaccines then it should be removed.”<o:p></o:p></p>
<p class="MsoNormal">Thimerosal used as a preservative in vaccines given to children is a high crime against our civilization and all that is good in the field of medicine. Recommended and given to children 6 months and older by pediatricians since 2004, and annually to children until they turn 18, (and in 2009 in the A-H1N1 vaccine) one can only wonder where we have gone so utterly wrong injecting our babies and children with the third most toxic element known to mankind. “These injections exceed the <st2:personname w:st="on"><st1:givenname w:st="on">EPA</st1:givenname> <st1:middlename w:st="on">RfD</st1:middlename></st2:personname> mercury amount by a factor of 125 when the Thimerosal doses are 0.25-mL in each vaccine and by 250 times when the doses are set at 0.5-mL per injection. Typically a child getting the 0.25-mL dose weighs less than 18 kg (and at six months much less) and the older children who gets the 0.5-mL dose typically weighs much less than 70 kg,” reports Dr. Paul King.[1]<o:p></o:p></p>
<p class="MsoNormal">It seems like Pediatricians just cannot do the math or are just too lazy to do so. The EPA’s reference dose (RfD) for mercury is 0.1 microgram of mercury per kilogram of weight per day for ingested mercury, which is the legally considered adequate safety level. So how can anyone in their right mind inject a small child with a 25-microgram dose when that passes the legal dose for a humongous adult? To meet the EPA standard a person would have to weigh 551 pounds to receive the 0.5-mL vaccine dose (50 mcg) and the little baby would have to weigh 225 pounds to redeem the attending pediatrician. In some countries they inject newborns on their first day of life with 50 mcg doses and one can only wonder what children today would be like in the third world if they did not receive the Hepatitis B shots at birth.<o:p></o:p></p>
<p class="MsoNormal">Dr. <st1:sn w:st="on">King</st1:sn> asks, “How can Thimerosal used as a preservative be safe when the toxicity studies required by law (21 CFR 610.15(a)) since the late 1960s have NOT been conducted (as the FDA and the vaccine makers have repeatedly admitted or failed to refute? How is a dose of mercury that exceeds the putative &#8220;safe level&#8221; (the putative no observed adverse-effect level [NOAEL]) for injected Thimerosal-related mercury (based on a chronic toxicity study in rats that is cited and recognized by the FDA) of &lt; 0.0042 micrograms of mercury per kilogram of weight per day for developing humans by more than a factor of 2900 for a 0.25-mL dose or more than a factor of 5900 for a 0.5-mL dose be considered either safe or minuscule?”.<o:p></o:p></p>
<p class="MsoNormal">A quote from researcher <st2:personname w:st="on"><st1:givenname w:st="on">David</st1:givenname> <st1:sn w:st="on">Geier</st1:sn>, <st1:namesuffix w:st="on">MD</st1:namesuffix></st2:personname>, PhD: &#8220;We went to Atlanta,&#8221; he continues, &#8220;to the CDC, and looked at the VSD [Vaccine Safety Data] data. There is thimerosal-containing DTaP [diphtheria, tetanus and pertussis vaccine] and thimerosal-free DTaP, so we asked a question: Among children that got a minimum of either three consecutive thimerosal-containing DTaPs or<span>   </span>three consecutive thimerosal-free DTaPs, was there a difference in the number of autism cases in the two groups? We found mega differences. More than 20 times higher. The rate of autism in the children that got more than three doses of thimerosal-containing DTaP vaccines was much, much higher. Almost all the children that have autism in that group were the ones that got the thimerosal-containing DTaP vaccine. The more thimerosal the greater the cases of autism.&#8221;<o:p></o:p></p>
<p class="MsoNormal">A 1991 Merck memo (released 2005) shows that at least one major manufacturer was aware of the vaccine mercury concern much earlier. The 1991 memo stated 6-month-old children who received their shots on schedule would get a mercury dose up to 87 times higher than guidelines (FDA) for the maximum daily consumption of mercury from fish. &#8220;When viewed in this way, the mercury load appears rather large,&#8221; said the memo from <st2:personname w:st="on"><st1:title w:st="on">Dr.</st1:title> <st1:givenname w:st="on">Maurice</st1:givenname>  <st1:middlename w:st="on">R.</st1:middlename> <st1:sn w:st="on">Hilleman</st1:sn></st2:personname>, an internationally renowned vaccinologist to the president of Merck’s vaccine division. &#8220;It is reasonable to conclude&#8221; that it should be eliminated where possible, he said, &#8220;especially where use in infants and young children is anticipated.&#8221;<o:p></o:p></p>
<p class="MsoNormal">A special federal court ruled against parents who claimed childhood vaccines had caused their children to develop autism. The &#8220;vaccine court&#8221; examined the evidence presented and concluded, &#8220;It was abundantly clear that the petitioners’ theories of causation were speculative and unpersuasive.&#8221; What is abundantly clear is that a court ruling has nothing to do with either science or the reality of one of the most toxic substances known to man and its effect on children. It does not matter what anyone says; nothing and no one will remove the skull and crossbones label from Thimerosal, meaning no one can remove the immanent dangers to child if this substance is injected.<o:p></o:p></p>
<p class="MsoNormal">“There is no convincing evidence that thimerosal is a factor in the onset of<o:p></o:p></p>
<p class="MsoNormal">autism” is the mantra of medical officials, and no matter how wrong, mean,<o:p></o:p></p>
<p class="MsoNormal">stupid, and ugly these officials are they remain publically and legally right.<o:p></o:p></p>
<p class="MsoNormal">Not everyone has been convinced nor has anyone approved the government’s effort to cover up the dangers of thimerosal. <st2:personname w:st="on">Rep. <st1:givenname w:st="on">Dan</st1:givenname> <st1:sn w:st="on">Burton</st1:sn></st2:personname>, a Republican from <st1:sn w:st="on">Indiana</st1:sn>, oversaw a three-year investigation of thimerosal after his grandson was diagnosed with autism. &#8220;Thimerosal used as a preservative in vaccines is directly related to the autism epidemic,&#8221; his House Government Reform Committee concluded in its final report. &#8220;This epidemic in all probability may have been prevented or curtailed had the FDA not been asleep at the switch regarding a lack of safety data regarding injected thimerosal, a known neurotoxin.&#8221; The FDA and other public-health agencies failed to act, the committee added, out of &#8220;institutional malfeasance for self protection&#8221; and &#8220;misplaced protectionism of the pharmaceutical industry.&#8221;<o:p></o:p></p>
<p class="MsoNormal">Few studies of the toxicity of Thimerosal in humans have been performed and yet the CDC and the FDA consider it safe. What is clear is that these organizations do not protect the public from obvious dangers having sold their souls to pharmaceutical interests. Cases have been reported of severe poisoning by accidental exposure or attempted suicide, with some fatalities to Thimerosal. Animal experiments suggest that Thimerosal rapidly dissociates to release ethyl mercury after injection; that the disposition patterns of mercury are similar to those after exposure to equivalent doses of ethylmercury chloride; and that the central nervous system and the kidneys are targets, with lack of motor coordination being a common sign.<o:p></o:p></p>
<p class="MsoNormal">So display some medical integrity and join with all doctors and healers everywhere and just say no to this madness. Tell your patients to avoid vaccines like the plague because the umbrella organizations like the CDC and the FDA have been compromised and cannot be trusted. One must not lay ones child on the alter of the dirtiest bastards that have ever walked our earth, monsters that would defend the injection of newborn babies with thousands of trillions of molecules of ethyl-mercury.<o:p></o:p></p>
<p class="MsoNormal">Defending the use of mercury in vaccines is a direct vote for this practice anywhere on the planet it is happening and makes one responsible, in part, for it. We have all inadvertently defended its use, for we continue to allow it to happen, but it has not been clear how to stop the medical officials and all those who support them.<o:p></o:p></p>
<p class="MsoNormal">Let’s at least turn our backs on the medical establishment on this one form of medical lunacy that implicates us all in a civilization disruptive practice that targets the young with illegal and humane medical mistreatment. Even if you are afraid to go on public record as taking a medical stand against medical officials and their untrustworthy pronouncements commit oneself to quietly handing out this document to patients telling them that we cannot support any part of the vaccination program because you cannot trust the principle organizations and people involved because of the Thimerosal cover-up. Explain to them that just like you would not support the use of a dangerous car or spoiled and tainted foods you cannot support the outrageous stonewalling of Thimerosal and its use one more day.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/03/02/read-this-before-vaccinating-your-child/feed/</wfw:commentRss>
		<slash:comments>7</slash:comments>
		</item>
		<item>
		<title>Liquid Vitamins Or Chewable Vitamins, Which Is Best</title>
		<link>http://www.epatienthealthcare.com/blog/2010/03/01/liquid-vitamins-or-chewable-vitamins-which-is-best/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/03/01/liquid-vitamins-or-chewable-vitamins-which-is-best/#comments</comments>
		<pubDate>Tue, 02 Mar 2010 01:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Vitamins - Supplements]]></category>
		<category><![CDATA[]]></category>
		<category><![CDATA[acupuncture]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[chronic pain]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[E-Care Plan]]></category>
		<category><![CDATA[E-Patients]]></category>
		<category><![CDATA[fibromyalgia]]></category>
		<category><![CDATA[health. healthcare]]></category>
		<category><![CDATA[herbal supplements]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Internet]]></category>
		<category><![CDATA[natural health]]></category>
		<category><![CDATA[Reimbursement]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>
		<category><![CDATA[vitamins, supplements]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/2010/03/01/liquid-vitamins-or-chewable-vitamins-which-is-best/</guid>
		<description><![CDATA[Nearly 50% of Americans residing in the United States use some type of vitamin or vitamin supplement ever day. Even though they may take vitamins, most are unaware of the fact that nearly 90% of the nutrients and minerals found in the vitamin isn’t properly absorbed by the body, which means they are virtually watered [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" /><o:smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PersonName"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="GivenName"></o:smarttagtype><o:smarttagtype namespaceuri="urn:schemas:contacts" name="Sn"></o:smarttagtype>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object  classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object><br />
<style> st2\:*{behavior:url(#ieooui) }st1\:*{behavior:url(#ieooui) } </style>
<p> <![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">Nearly 50% of Americans residing in the United States use some type of vitamin or vitamin supplement ever day. Even though they may take vitamins, most are unaware of the fact that nearly 90% of the nutrients and minerals found in the vitamin isn’t properly absorbed by the body, which means they are virtually watered down and most of their benefits proven to be not effective.</p>
<p class="MsoNormal">Almost all individuals who take vitamins use the pill form. Pills were once thought of to be the best, simply because they were the only vitamin sources. These days, liquid vitamins are much more effective, and people are starting to realize it. Although many use pills or chewable vitamins, they aren’t getting near the benefit they think they are.</p>
<p class="MsoNormal">Vitamins and supplements are very popular, especially for those who have active lifestyles and find it difficult to consume the necessary vitamins and minerals they need from the proper meals. Therefore, those with busy lifestyles turn to vitamins and supplements to give their bodies what it needs to carry out day to day activities. Even though you should never replace food with vitamins, vitamins can help you to get the nutrients and minerals you need on a daily basis.</p>
<p class="MsoNormal">The main reason why liquid vitamins are more effective than pills and tablets is due to the nature of their liquid base. With the vitamins being liquid, they are easier for the body to digest and easily absorbed into the digestive tract as well. Chewable tablets and pills will pass through the body in hard form, making them hard to digest. Liquid is always digested when it passes through, so it will go through your body quicker and take effect faster.</p>
<p class="MsoNormal">Due to the body having to work less to break down and absorb liquid vitamins, they will pass through the body much faster. The nutrients and minerals contained in liquid vitamins will reach vital areas faster through the bloodstream, and they are easier to use by the most important organs in your body that need them the most. Liquid is also easy to swallow as well, as you can add the liquid vitamin to your favorite juice or just take it right out of the bottle if you prefer.</p>
<p class="MsoNormal">With pills or chewable vitamins, the majority of the nutrients and minerals that are contained in the vitamins aren’t normally broken down in the digestive system. With these types of vitamins being in hard form, they are harder for the body to pass at the most crucial moments, where the body needs to have nutrients and minerals. Unless you completely chew up the vitamin, it can stay in hard form until it passes through when you go to the bathroom. If this happens, you are normally just wasting the vitamin as it doesn’t have a chance to get into the bloodstream.</p>
<p class="MsoNormal">Liquid vitamins have proven themselves to be the best way to get the minerals and nutrients your body needs. As more and more people discover the benefits of liquid vitamins and how easy they are to digest, they make the switch. Liquid is far superior to tablets and pills, simply because it tastes better, it’s easier to digest, and it travels through the body faster. You can find many different flavors and types of vitamin supplements at your local nutrition store, or get online and order what you need there. Either way you go &#8211; you’ll find liquid vitamins to be the ideal way to get the nutrients you need for you body on a daily basis.</p>
<p class="MsoNormal">By – <st2:personname w:st="on"><st1:givenname w:st="on">P.</st1:givenname>  <st1:sn w:st="on">Stevens</st1:sn></st2:personname></p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/03/01/liquid-vitamins-or-chewable-vitamins-which-is-best/feed/</wfw:commentRss>
		<slash:comments>25</slash:comments>
		</item>
		<item>
		<title>Surge In Infertility Tourism Leads to Viking Babies</title>
		<link>http://www.epatienthealthcare.com/blog/2010/03/01/surge-in-infertility-tourism-leads-to-viking-babies/</link>
		<comments>http://www.epatienthealthcare.com/blog/2010/03/01/surge-in-infertility-tourism-leads-to-viking-babies/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 18:32:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[Lifestyle Health]]></category>
		<category><![CDATA[Odd Medical Practices]]></category>
		<category><![CDATA[]]></category>
		<category><![CDATA[alternative medicine]]></category>
		<category><![CDATA[cam]]></category>
		<category><![CDATA[complementary medicine]]></category>
		<category><![CDATA[E Patient]]></category>
		<category><![CDATA[E-Patient Health Care]]></category>
		<category><![CDATA[fertilization]]></category>
		<category><![CDATA[in vitro]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[PREGANANCY]]></category>
		<category><![CDATA[Reimbursement]]></category>
		<category><![CDATA[sperm]]></category>
		<category><![CDATA[US Tele-Medicine]]></category>
		<category><![CDATA[US Telemedicine]]></category>

		<guid isPermaLink="false">http://www.epatienthealthcare.com/blog/2010/03/01/surge-in-infertility-tourism-leads-to-viking-babies/</guid>
		<description><![CDATA[LONDON &#8211; In vitro fertilization (IVF) has become a popular method by which women who are having trouble getting pregnant are able to use donor sperm to achieve pregnancy. In the UK, however, there is a shortage of donor sperm that is causing British women to have to travel to countries like Denmark in order [...]]]></description>
			<content:encoded><![CDATA[<p><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ProgId" content="Word.Document" /><meta name="Generator" content="Microsoft Word 12" /><meta name="Originator" content="Microsoft Word 12" /></p>
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml" rel="File-List" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx" rel="themeData" />
<link href="file:///C:%5CUsers%5CJvS%5CAppData%5CLocal%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml" rel="colorSchemeMapping" /><!--[if gte mso 9]><xml>  <w:WordDocument>   <w:View>Normal</w:View>   <w:Zoom>0</w:Zoom>   <w:TrackMoves/>   <w:TrackFormatting/>   <w:PunctuationKerning/>   <w:ValidateAgainstSchemas/>   <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>   <w:IgnoreMixedContent>false</w:IgnoreMixedContent>   <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>   <w:DoNotPromoteQF/>   <w:LidThemeOther>EN-US</w:LidThemeOther>   <w:LidThemeAsian>X-NONE</w:LidThemeAsian>   <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>   <w:Compatibility>    <w:BreakWrappedTables/>    <w:SnapToGridInCell/>    <w:WrapTextWithPunct/>    <w:UseAsianBreakRules/>    <w:DontGrowAutofit/>    <w:SplitPgBreakAndParaMark/>    <w:DontVertAlignCellWithSp/>    <w:DontBreakConstrainedForcedTables/>    <w:DontVertAlignInTxbx/>    <w:Word11KerningPairs/>    <w:CachedColBalance/>   </w:Compatibility>   <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>   <m:mathPr>    <m:mathFont m:val="Cambria Math"/>    <m:brkBin m:val="before"/>    <m:brkBinSub m:val="&#45;-"/>    <m:smallFrac m:val="off"/>    <m:dispDef/>    <m:lMargin m:val="0"/>    <m:rMargin m:val="0"/>    <m:defJc m:val="centerGroup"/>    <m:wrapIndent m:val="1440"/>    <m:intLim m:val="subSup"/>    <m:naryLim m:val="undOvr"/>   </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml>  <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267">   <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal"/>   <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>   <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>   <w:LsdException Locked="false" Priority="39" Name="toc 1"/>   <w:LsdException Locked="false" Priority="39" Name="toc 2"/>   <w:LsdException Locked="false" Priority="39" Name="toc 3"/>   <w:LsdException Locked="false" Priority="39" Name="toc 4"/>   <w:LsdException Locked="false" Priority="39" Name="toc 5"/>   <w:LsdException Locked="false" Priority="39" Name="toc 6"/>   <w:LsdException Locked="false" Priority="39" Name="toc 7"/>   <w:LsdException Locked="false" Priority="39" Name="toc 8"/>   <w:LsdException Locked="false" Priority="39" Name="toc 9"/>   <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>   <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title"/>   <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>   <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>   <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong"/>   <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>   <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>   <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>   <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>   <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>   <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote"/>   <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>   <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6"/>   <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6"/>   <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6"/>   <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>   <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>   <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>   <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>   <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>   <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>   <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>   <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6"/>   <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>   <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6"/>   <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>   <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>   <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>   <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>   <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>   <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>   <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>   <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>  </w:LatentStyles> </xml><![endif]--><br />
<style> <!--  /* Font Definitions */  @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --> </style>
<p><!--[if gte mso 10]><br />
<style>  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} </style>
<p> <![endif]--></p>
<p class="MsoNormal">LONDON &#8211; In vitro fertilization (IVF) has become a popular method by which women who are having trouble getting pregnant are able to use donor sperm to achieve pregnancy. In the UK, however, there is a shortage of donor sperm that is causing British women to have to travel to countries like Denmark in order to find some.<o:p></o:p></p>
<p class="MsoNormal">A 2005 British law change outlawed the donating of sperm anonymously. UK law also has a long-standing rule that prohibits men who donate from receiving any sort of monetary compensation. Because of these rules, and the fact that many men fear having to provide their identities with the donation because the children may eventually try to find and meet them, few British men are donating sperm these days. As a result, the waiting list to receive IVF in the UK is several years.<o:p></o:p></p>
<p class="MsoNormal">In 2007, Denmark changed its laws and now permits anonymous donors, which has led to a surge in foreign women coming there to receive IVF treatment. Danish donors are also compensated between $60 and $200 for their donations which has helped to facilitate a large number of casual donors. The Danish sperm bank, Cryos, is the largest sperm bank in the world and is a popular destination for &#8220;infertility tourists&#8221; seeking to have children.<o:p></o:p></p>
<p class="MsoNormal">Denmark is one of the few nations that allows anonymous donations as well as monetary compensation for them. For this reason, Danish clinics are flourishing with increased business. DanFert in Copenhagen more than doubled its IVF customers since 2007. Vita Nova in Copenhagen has seen a 40 percent increase in women seeking IVF from Britain alone.<o:p></o:p></p>
<p class="MsoNormal">Danish clinics also cater to single women who are trying to have children, a controversial scenario rejected by many other nations who aim to serve couples trying to conceive. Such liberal laws have attracted all sorts of women from around the globe who wish to bear children but are otherwise unable.<o:p></o:p></p>
<p class="MsoNormal">Because of the popularity of the program, Danish banks have begun opening up franchised fertility clinics in other countries that permit it, including in the US and India. In these countries, men who are looking to make some extra cash often donate to the clinic, a practice that has all but ceased in Britain due to the laws.<o:p></o:p></p>
<p class="MsoNormal">Many women are hoping that UK laws will once again allow for anonymous sperm donors. They believe it will help to increase supply and end the shortage that has prevented many women from receiving IVF there.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.epatienthealthcare.com/blog/2010/03/01/surge-in-infertility-tourism-leads-to-viking-babies/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk
Page Caching using disk (enhanced)
Database Caching 41/206 queries in 0.072 seconds using disk
Object Caching 2051/2285 objects using disk

Served from: www.epatienthealthcare.com @ 2012-02-11 17:29:42 -->
